var title_f15_36_15936="Disseminated granuloma annulare - multiple papules";
var content_f15_36_15936=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F53172&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F53172&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Disseminated granuloma annulare",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 316px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This 40 year-old patient presented with over 100 discrete 1-2 mm erythematous papules over the arms and legs with just a few similar lesions on the trunk.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_36_15936=[""].join("\n");
var outline_f15_36_15936=null;
var title_f15_36_15937="Subglottic hemangioma";
var content_f15_36_15937=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F73275&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F73275&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Endoscopic view of subglottic hemangioma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 370px; height: 367px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Note the red-blue sessile lesion in the posterolateral subglottis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Glenn C Isaacson, MD, FAAP, FACS.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_36_15937=[""].join("\n");
var outline_f15_36_15937=null;
var title_f15_36_15938="Overdistended bladder mimicking placenta previa";
var content_f15_36_15938=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F76545&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F76545&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Overdistended bladder mimicking placenta previa",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 380px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Transabdominal study shows an over-distended bladder giving the appearance of a previa in a patient with&nbsp;NO placenta previa. An over-distended bladder can compress the anterior lower uterine segment against the posterior lower uterine segment, thereby mimicking placenta previa. The arrow points to the cervical os.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Deborah Levine, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_36_15938=[""].join("\n");
var outline_f15_36_15938=null;
var title_f15_36_15939="Type III hiatal hernia UGI";
var content_f15_36_15939=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F50536&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F50536&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Type III hiatal hernia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 217px; height: 358px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Upper GI series showing a type III hiatal hernia. Type III hernias have elements of both types I and II. With progressive enlargement of the hernia through the hiatus, the phrenoesophageal membrane stretches, displacing the gastroesophageal junction above the diaphragm, thereby adding a sliding element to the type II hernia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reprinted with permission from: Peridikis G, Hinder RA. Paraesophageal hiatal hernia. In: Hernia, Nyhus LM, Condon RE (Eds), JB Lippincott, Philadelphia 1995. p.544.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal upper GI series",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 286px; height: 330px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal air-contrast upper gastrointestinal study showing normal gastric folds and small intestinal anatomy, and no masses.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul C Schroy III, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_36_15939=[""].join("\n");
var outline_f15_36_15939=null;
var title_f15_36_15940="Female genital HSV";
var content_f15_36_15940=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F58485&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F58485&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Female genital herpes simplex virus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_36_15940=[""].join("\n");
var outline_f15_36_15940=null;
var title_f15_36_15941="2D TTE parasternal long axis";
var content_f15_36_15941=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F77446%7ECARD%2F75034&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F77446%7ECARD%2F75034&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Two-dimensional transthoracic echocardiogram (2D TTE) parasternal long axis view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 401px; height: 299px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This parasternal long axis echocardiogram was obtained in systole; the aortic valve is open and the mitral is closed.",
"    <div class=\"footnotes\">",
"     RV: right ventricle; IVS: interventricular septum; NCC: noncoronary cusp of the aortic valve; PW: posterior left ventricle wall; RCC: right coronary cusp of the aortic valve; aML: anterior mitral valve leaflet; pML: posterior mitral valve leaftlet; dAo: descending aorta.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Apical four-chamber echocardiographic view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 352px; height: 311px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Apical four-chamber view from a&nbsp;two-dimensional&nbsp;echocardiogram. The display shows the apex at the top of the screen with the left ventricle (LV) to the viewer's right.",
"    <div class=\"footnotes\">",
"     aML: anterior mitral leaflet; LA: left atrium; pML: posterior mitral valve leaflet; RA: right atrium; RV: right ventricle.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_36_15941=[""].join("\n");
var outline_f15_36_15941=null;
var title_f15_36_15942="Mediastinal benign schwannoma 1";
var content_f15_36_15942=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F60032&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F60032&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mediastinal benign schwannoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 227px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Spindle cell neoplasm demonstrates hypercellular areas (Antoni A on the left) and edematous, hypocellular areas (Antoni B on the right). Verocay bodies composed of two parallel rows of palisading nuclei are seen within the hypercellular areas. (Hematoxylin and eosin, magnification 50x).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William Travis, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_36_15942=[""].join("\n");
var outline_f15_36_15942=null;
var title_f15_36_15943="Bradykinetic movement disorders in children";
var content_f15_36_15943=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Bradykinetic movement disorders in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/36/15943/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/36/15943/contributors\">",
"     Joseph Jankovic, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/36/15943/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/36/15943/contributors\">",
"     Marc C Patterson, MD, FRACP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/36/15943/contributors\">",
"     Helen V Firth, DM, FRCP, DCH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/36/15943/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/36/15943/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?15/36/15943/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Movement disorders are characterized by either reduced (bradykinetic) or excessive (hyperkinetic) activity. Bradykinetic movement disorders frequently are accompanied by rigidity, postural instability, and loss of automatic associated movements. Diagnosis of the specific condition depends primarily upon careful observation of the clinical features [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15943/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bradykinetic disorders are reviewed here. Many such disorders, mostly rare, exist and only four are discussed here:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Parkinson disease",
"     </li>",
"     <li>",
"      Wilson disease",
"     </li>",
"     <li>",
"      Huntington disease",
"     </li>",
"     <li>",
"      Neurodegeneration with brain iron accumulation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Hyperkinetic disorders are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/40/18058?source=see_link\">",
"     \"Hyperkinetic movement disorders in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ANATOMY OF THE BASAL GANGLIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;A brief review of the anatomy of the basal ganglia is appropriate because this site is involved in many of the bradykinetic disorders. The basal ganglia regulate the initiation, scaling, and control of the amplitude and direction of movement. Movement disorders can result from biochemical or structural abnormalities in these structures.",
"   </p>",
"   <p>",
"    The basal ganglia are a complex of deep nuclei that consist of the corpus striatum, globus pallidus, and substantia nigra. The corpus striatum, which includes the caudate nucleus and the putamen, receives input from the cerebral cortex and the thalamus and, in turn, projects to the globus pallidus.",
"   </p>",
"   <p>",
"    The substantia nigra is divided into the dopamine-rich pars compacta and the less dense pars reticularis. The pars reticularis is similar histologically and chemically to the medial segment of the globus pallidus, and both project via the thalamus to the premotor and motor cortex. The substantia nigra pars compacta gives rise to the nigral-striatal pathway, which is the main dopaminergic tract.",
"   </p>",
"   <p>",
"    The output of the basal ganglia projects by way of the thalamus to the cerebral cortex and then to the pyramidal system. Basal ganglia output is sometimes referred to as the extrapyramidal system, a term now less commonly used, because it was once thought to be in parallel with the pyramidal system. Integration of the basal ganglia with the cortex facilitates motor control.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PARKINSON DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bradykinetic movement disorders are characterized by slowness of movement and consist predominantly of conditions with features of parkinsonism, of which Parkinson disease (PD) is the most prominent example (",
"    <a class=\"graphic graphic_table graphicRef80669 \" href=\"UTD.htm?39/19/40253\">",
"     table 1",
"    </a>",
"    ). Other characteristic motor findings of PD include tremor at rest, rigidity, and gait disturbance. In addition, nonmotor symptoms are also increasingly recognized components of PD. These include olfactory deficit, behavioral, cognitive, and sleep deficits, and dysautonomia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/13/14554?source=see_link\">",
"     \"Clinical manifestations of Parkinson disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    PD typically presents in middle and late life. However, early-onset disease can occur before age 40 years, and a juvenile form presents before age 20 [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15943/abstract/2\">",
"     2",
"    </a>",
"    ]. Dystonia (often involving the legs), levodopa-induced dyskinesia, and levodopa-related motor fluctuations (eg, \"wearing off\" and \"on-off\" responses several hours following a dose) are common in the young-onset and juvenile forms of PD [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15943/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/40/18058?source=see_link&amp;anchor=H5#H5\">",
"     \"Hyperkinetic movement disorders in children\", section on 'Dystonia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most cases of PD are sporadic, but genetic loci (PARK1 through PARK15) have been associated with autosomal dominant or recessive PD or parkinsonism. The genetic causes of PD are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/6/36970?source=see_link&amp;anchor=H16#H16\">",
"     \"Etiology and pathogenesis of Parkinson disease\", section on 'Genetics'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The diagnosis of juvenile parkinsonism is based on clinical signs. Patients have gradual onset of slowness of movement, tremors in the hands or legs (but not the head), rigidity of muscles, shuffling gait, and postural instability. Other signs include lack of facial expression (hypomimia), drooling, dysarthria, and dystonia (involuntary spasms and abnormal postures of hands and feet).",
"   </p>",
"   <p>",
"    Levodopa is the most effective drug in the treatment of PD [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15943/abstract/4\">",
"     4",
"    </a>",
"    ]. However, most patients develop abnormal involuntary movements (dyskinesia) and unpredictable fluctuations in motor functioning within three years of treatment. Patients with onset before age 40 years are most likely to be affected. As a result, particularly in young patients, therapy is often initiated with other drugs that will control the symptoms and delay the need for levodopa. They include anticholinergic drugs (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?17/52/18244?source=see_link\">",
"     trihexyphenidyl",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/62/17383?source=see_link\">",
"     amantadine",
"    </a>",
"    ) and dopamine agonists (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/19/32055?source=see_link\">",
"     pramipexole",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/11/18615?source=see_link\">",
"     ropinirole",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/63/32762?source=see_link\">",
"     \"Pharmacologic treatment of Parkinson disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Complications of levodopa are managed by adjusting the dosage and frequency of administration. If these changes do not alleviate symptoms, surgical treatment, such as high frequency stimulation of the subthalamic nucleus or globus pallidus, is considered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     WILSON DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Wilson disease (hepatolenticular degeneration) is a treatable cause of juvenile parkinsonism, dystonia, tremor, and other movement disorders. This rare disorder has an estimated prevalence of 30 per million.",
"   </p>",
"   <p>",
"    Wilson disease is an autosomal recessive defect of cellular copper export. The major abnormality is reduced biliary excretion of copper that leads to its accumulation, initially in the liver and then in other tissues, particularly the brain. Tissue copper deposition causes a multitude of signs and symptoms that reflect hepatic, neurologic, hematologic, and renal impairment. The incorporation of copper into ceruloplasmin is also impaired.",
"   </p>",
"   <p>",
"    Clinical aspects of Wilson disease are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/37/13910?source=see_link\">",
"     \"Epidemiology and pathogenesis of Wilson disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/48/14088?source=see_link\">",
"     \"Tests used in the diagnosis of Wilson disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/11/23737?source=see_link\">",
"     \"Treatment of Wilson disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     HUNTINGTON DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Huntington disease (HD) typically presents during the fourth and fifth decades of life; however, onset occurs during childhood or adolescence in approximately 5 to 7 percent of affected patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Genetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;The genetics and pathogenesis of HD are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/25/8599?source=see_link\">",
"     \"Huntington disease: Genetics and pathogenesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Reviewed briefly, HD is transmitted as an autosomal dominant trait with the affected gene being on the short arm of chromosome 4. Juvenile onset disease shows a major transmitting parent effect, as approximately 80 percent of symptomatic patients inherit the mutant HD gene from their father [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15943/abstract/5\">",
"     5",
"    </a>",
"    ]. The high number of cellular divisions that occur during spermatogenesis likely accounts for the pronounced paternal-repeat instability.",
"   </p>",
"   <p>",
"    HD is one of a number of disorders that are associated with expansion of unstable trinucleotide (CAG) repeats that encode for polyglutamine tracts in the protein products. There is mounting evidence that fragments of the huntingtin protein containing expanded polyglutamine tracts may be neurotoxic. The greater the number of CAG repeats on expanded alleles, the earlier the age of onset and more severe the disease.",
"   </p>",
"   <p>",
"    Demonstration of more than 36 CAG repeats in one of the alleles in the HD gene confirms the diagnosis of HD. Alleles with 27 to 35 CAG repeats are termed intermediate alleles. An individual with an allele in this range is not at risk of developing symptoms of HD, but may be at risk of having a child with an allele in the disease range. Juvenile forms are associated with alleles containing more than 60 to 70 repeats and, in some patients, more than 100 repeats.",
"   </p>",
"   <p>",
"    The inverse relationship between age of onset and number of CAG repeats was confirmed in a Dutch cohort of 755 affected patients [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15943/abstract/6\">",
"     6",
"    </a>",
"    ]. The correlation was stronger for paternal than maternal inheritance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with juvenile-onset HD develop dystonia, ataxia, and seizures. Most of them have the akinetic-rigid syndrome termed the Westphal variant. Approximately one-fourth have the classic feature of chorea seen in adults. Children also have more rapidly progressive disease than adults.",
"   </p>",
"   <p>",
"    Biochemical changes observed in the brains of adults with HD may explain the neurologic features. Glutamic acid decarboxylase activity is reduced, especially in the corpus striatum, substantia nigra, and other basal ganglia. In contrast, thyrotropin-releasing hormone, neurotensin, somatostatin, and neuropeptide Y are increased in the corpus striatum. The depletion of gamma-aminobutyric acid in the corpus striatum may result in disinhibition of the nigral-striatal pathway. Coupled with the accumulation of somatostatin, the net result may be the release of striatal dopamine, which results in chorea.",
"   </p>",
"   <p>",
"    The pattern of brain abnormality depends upon the age of onset. The characteristic pathologic change in adults with HD is diffuse, marked atrophy of the neostriatum that may be worse in the caudate than in the putamen. The changes are more dramatic in early-onset HD. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/25/8599?source=see_link&amp;anchor=H8#H8\">",
"     \"Huntington disease: Genetics and pathogenesis\", section on 'Neuropathology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The reasons for the selective vulnerability of the medium spiny neurons in the striatum is not known, but some insight may be gained from the study of Rhes (Ras homolog enriched in striatum), a small guanine nucleotide-binding protein that is selectively localized to the striatum and to a much lesser extent in the cortex, but not in the cerebellum. Rhes binds physiologically to mutated huntingtin and leads to selective cytotoxicity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/25/8599?source=see_link&amp;anchor=H7#H7\">",
"     \"Huntington disease: Genetics and pathogenesis\", section on 'Rhes'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;No cure or disease-modifying treatment is currently available for HD [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15943/abstract/7\">",
"     7",
"    </a>",
"    ]. Therapy is focused on symptom management and supportive care in order to optimize quality of life. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/29/39385?source=see_link\">",
"     \"Huntington disease: Management\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The impact of chorea in patients with HD should be carefully assessed to determine whether any specific treatment is necessary, since it may not be a debilitating or bothersome symptom, particularly in early stages. Pharmacologic treatment of chorea may worsen other aspects of HD, including parkinsonism, cognition, and mood. When chorea does become severe, padded reclining chairs and bed padding are recommended to reduce the risk of injury.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/31/32246?source=see_link\">",
"     Tetrabenazine",
"    </a>",
"    , a presynaptically acting dopamine depleting agent, can be useful for controlling chorea in patients with HD. Compared with the typical neuroleptics, one of the advantages of tetrabenazine is that it does not cause tardive dyskinesia. However, tetrabenazine treatment was associated with significantly more adverse events than placebo treatment in randomized trials. Dose-limiting symptoms with tetrabenazine included sedation, akathisia, parkinsonism, and depressed mood; these generally resolved with dosage adjustments. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/29/39385?source=see_link&amp;anchor=H6#H6\">",
"     \"Huntington disease: Management\", section on 'Tetrabenazine'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients with HD who have moderately severe chorea that does not respond to nonpharmacologic intervention, we suggest initial treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/31/32246?source=see_link\">",
"     tetrabenazine",
"    </a>",
"    rather than dopamine receptor blocking drugs (neuroleptics) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15943/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. For chorea that does not respond to tetrabenazine, additional treatment options include atypical and typical neuroleptics. Beyond these, alternatives include",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/62/17383?source=see_link\">",
"     amantadine",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/0/25608?source=see_link\">",
"     levetiracetam",
"    </a>",
"    , and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/60/21448?source=see_link\">",
"     topiramate",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/29/39385?source=see_link&amp;anchor=H12#H12\">",
"     \"Huntington disease: Management\", section on 'Choosing interventions for chorea'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Levodopa may provide symptomatic relief of the parkinsonian features of childhood HD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Future directions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many different potential therapies have shown some promise in animal models of HD. These include coenzyme Q10, creatine, cystamine,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/61/7124?source=see_link\">",
"     cysteamine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/31/22004?source=see_link\">",
"     riluzole",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15943/abstract/10-12\">",
"     10-12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/29/39385?source=see_link&amp;anchor=H18#H18\">",
"     \"Huntington disease: Management\", section on 'Investigational therapies'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     NEURODEGENERATION WITH BRAIN IRON ACCUMULATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neurodegeneration with brain iron accumulation (NBIA) is a rare progressive neurodegenerative syndrome that causes parkinsonism, dystonia, cognitive decline, and other neurologic deficits. NBIA is now considered a spectrum of phenotypically overlapping disorders, with several subtypes defined by differences at the molecular genetic level [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15943/abstract/13-16\">",
"     13-16",
"    </a>",
"    ]. These subtypes are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pantothenate kinase-associated neurodegeneration (PKAN), formerly known as Hallervorden-Spatz disease, caused by mutations in the gene encoding pantothenate kinase 2 (PANK2) [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15943/abstract/17,18\">",
"       17,18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Infantile neuroaxonal dystrophy, an autosomal recessive disorder, caused by mutations in the PLA2G6 gene. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/37/602?source=see_link&amp;anchor=H2#H2\">",
"       \"Hereditary neuropathies associated with generalized disorders\", section on 'Infantile neuroaxonal dystrophy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Neuroferritinopathy, an adult-onset autosomal dominant basal ganglia disease characterized by variable symptoms that include parkinsonism, chorea, and dystonia [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15943/abstract/19\">",
"       19",
"      </a>",
"      ]. The disorder is caused by mutations in the ferritin light chain gene (FTL).",
"     </li>",
"     <li>",
"      Aceruloplasminemia, an adult-onset autosomal recessive disorder caused by mutations in the ceruloplasmin gene and characterized by ceruloplasmin deficiency, diabetes, dementia, parkinsonism, chorea, and ataxia [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15943/abstract/20,21\">",
"       20,21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Fatty acid hydroxylase-associated neurodegeneration (FAHN), a childhood-onset disorder characterized by gait impairment, spastic paraparesis, ataxia and dystonia caused by mutations in the FA2H gene [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15943/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      NBIA of unknown cause",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The following discussion will focus on NBIA of childhood onset, particularly PKAN. Infantile neuroaxonal dystrophy is reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/37/602?source=see_link&amp;anchor=H2#H2\">",
"     \"Hereditary neuropathies associated with generalized disorders\", section on 'Infantile neuroaxonal dystrophy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with NBIA have posture and gait abnormalities, bradykinesia, rigidity, and other parkinsonian features, including tremor. Affected patients may also have hyperkinetic movement disorders, such as dystonia and choreoathetosis, as well as progressive dysarthria, dementia, ataxia, spasticity, seizure disorder, optic atrophy, and retinitis pigmentosa.",
"   </p>",
"   <p>",
"    As noted above, many patients with NBIA have mutations in the gene encoding pantothenate kinase 2 (PANK2) and are said to have pantothenate kinase-associated neurodegeneration (PKAN) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15943/abstract/17,23,24\">",
"     17,23,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    PKAN is inherited in an autosomal recessive pattern, but NBIA also occurs sporadically, and some phenotypically similar cases appear to be transmitted in an autosomal dominant fashion.",
"   </p>",
"   <p>",
"    The relationship between genotype and phenotype was evaluated in a study of 123 patients from 98 families with NBIA [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15943/abstract/24\">",
"     24",
"    </a>",
"    ]. Two variants were distinguished:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Classic disease with early onset (typically in the first decade of life) and rapid progression",
"     </li>",
"     <li>",
"      Atypical disease with later onset (usually in the second or third decade of life) and slow progression",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    All patients with classic disease and one-third of those with atypical disease had PANK2 mutations [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15943/abstract/24\">",
"     24",
"    </a>",
"    ]. In this series, abnormalities in classic NBIA were noted with the following frequencies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Extrapyramidal signs including dystonia, dysarthria, rigidity, and choreoathetosis &mdash; 98 percent",
"     </li>",
"     <li>",
"      Retinopathy &mdash; 68 percent",
"     </li>",
"     <li>",
"      Cognitive decline &mdash; 29 percent",
"     </li>",
"     <li>",
"      Corticospinal tract involvement, including spasticity, hyperreflexia, and extensor toe signs &mdash; 25 percent",
"     </li>",
"     <li>",
"      Few patients had optic atrophy (3 percent) and none had seizures.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Prominent speech-related and psychiatric symptoms were common in patients with atypical disease and PANK2 mutations [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15943/abstract/24\">",
"     24",
"    </a>",
"    ]. In contrast, these symptoms were unusual in those with atypical disease without the mutations and in those with classic disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Neuroimaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients with PANK2 mutations, whether classic or atypical, had the characteristic radiologic sign known as \"eye of the tiger\" on brain MRI, with a central focus of increased T2 signal intensity in the medial globus pallidus surrounded by a zone of decreased signal [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15943/abstract/24\">",
"     24",
"    </a>",
"    ]. This sign was not seen in patients without PANK2 mutations. While considered a characteristic feature of PKAN, the eye of the tiger sign has also been reported in a minority of patients with neuroferritinopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15943/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of NBIA is based upon clinical features. The diagnosis of PKAN is suspected when a MRI scan shows a central focus of increased T2 signal intensity surrounded by a zone of decreased signal in the region of the globus pallidus (eye of the tiger sign) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15943/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Genetic sequence analysis for PANK2 mutations is recommended by some experts to confirm the diagnosis in those with suspected NBIA and the \"eye of the tiger\" MRI sign [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15943/abstract/16\">",
"     16",
"    </a>",
"    ]. Sequence analysis testing is available from several university-affiliated clinical laboratories in the US and Europe [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15943/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Pathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increased iron uptake is confirmed by postmortem examination, which reveals the characteristic pigmentary degeneration of the basal ganglia, particularly the internal segment of the globus pallidus and the zona reticularis of the substantia nigra. The pigmentary changes result from marked iron accumulation in these areas [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15943/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The mechanism by which basal ganglia iron uptake is increased in NBIA is not well understood. Systemic and cerebrospinal fluid iron levels, as well as plasma ferritin, transferrin, and ceruloplasmin, all are normal [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15943/abstract/18\">",
"     18",
"    </a>",
"    ]. Furthermore, disorders of systemic iron overload, such as hemochromatosis, are not associated with increased brain iron.",
"   </p>",
"   <p>",
"    Marked neuroaxonal degeneration with the formation of ubiquinated deposits and spheroids is another distinctive pathologic feature of pantothenate kinase-associated neurodegeneration [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15943/abstract/26\">",
"     26",
"    </a>",
"    ]. These glycoprotein-containing axonal swellings have been attributed to abnormal lipid membrane peroxidation. It may result from chelation of ferrous iron caused by increased cysteine (demonstrated in one patient with NBIA), leading to the accelerated generation of free hydroxyl radicals in the presence of non-protein-bound iron.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of NBIA, including iron chelation with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/0/37894?source=see_link\">",
"     deferoxamine",
"    </a>",
"    and antioxidant therapy, is ineffective. Levodopa and anticholinergic drugs may provide modest relief of parkinsonian symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H357217\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bradykinetic movement disorders frequently are accompanied by rigidity, postural instability, and loss of automatic associated movements. The basal ganglia are a complex of deep nuclei that consist of the corpus striatum, globus pallidus, and substantia nigra. These nuclei regulate the initiation, scaling, and control of the amplitude and direction of movement. Movement disorders can result from biochemical or structural abnormalities in these structures. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Anatomy of the basal ganglia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bradykinetic movement disorders are characterized by slowness of movement and consist predominantly of conditions with features of parkinsonism, of which Parkinson disease is the most prominent example (",
"      <a class=\"graphic graphic_table graphicRef80669 \" href=\"UTD.htm?39/19/40253\">",
"       table 1",
"      </a>",
"      ). Other characteristic motor findings of Parkinson disease include tremor at rest, rigidity, and gait disturbance. Nonmotor symptoms include olfactory deficit, behavioral, cognitive, and sleep deficits, and dysautonomia. Parkinson disease typically presents in middle and late life. However, early-onset disease can occur before age 40 years, and a juvenile form presents before age 20. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Parkinson disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Wilson disease (hepatolenticular degeneration) is a treatable cause of juvenile parkinsonism, dystonia, tremor, and other movement disorders. Clinical aspects of Wilson disease are discussed in detail separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/37/13910?source=see_link\">",
"       \"Epidemiology and pathogenesis of Wilson disease\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/48/14088?source=see_link\">",
"       \"Tests used in the diagnosis of Wilson disease\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/11/23737?source=see_link\">",
"       \"Treatment of Wilson disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Huntington disease typically presents during the fourth and fifth decades of life; however, onset occurs during childhood or adolescence in approximately 5 to 7 percent of affected patients. Patients with juvenile-onset Huntington disease develop dystonia, ataxia, and seizures. Most of them have the akinetic-rigid syndrome termed the Westphal variant. Approximately one-fourth have the classic feature of chorea seen in adults. Children also have more rapidly progressive disease than adults. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Huntington disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Neurodegeneration with brain iron accumulation (NBIA) is a rare progressive neurodegenerative syndrome that causes parkinsonism, dystonia, cognitive decline, and other neurologic deficits. NBIA is now considered a spectrum of phenotypically overlapping disorders, with several subtypes defined by differences at the molecular genetic level, including the following (see",
"      <a class=\"local\" href=\"#H10\">",
"       'Neurodegeneration with brain iron accumulation'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Pantothenate kinase-associated neurodegeneration, formerly known as Hallervorden-Spatz disease, caused by mutations in the PANK2 gene",
"     </li>",
"     <li>",
"      Infantile neuroaxonal dystrophy, an autosomal recessive disorder, caused by mutations in the PLA2G6 gene",
"     </li>",
"     <li>",
"      Neuroferritinopathy, an adult-onset autosomal dominant disease caused by mutations in the FTL gene and characterized by variable symptoms that include parkinsonism, chorea, and dystonia",
"     </li>",
"     <li>",
"      Aceruloplasminemia, an adult-onset autosomal recessive disorder caused by mutations in the CP gene and characterized by ceruloplasmin deficiency, diabetes, dementia, parkinsonism, chorea, and ataxia",
"     </li>",
"     <li>",
"      Fatty acid hydroxylase-associated neurodegeneration, a childhood-onset disorder caused by mutations in the FA2H gene and characterized by gait impairment, spastic paraparesis, ataxia and dystonia",
"     </li>",
"     <li>",
"      NBIA of unknown cause",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Jankovic J, Lang AE. Movement disorders: Diagnosis and assessment. In: Neurology in Clinical Practice, 5th ed, Bradley WG, Daroff RB, Fenichel GM, Jankovic J (Eds), Butterworth-Heinemann (Elsevier), Philadelphia 2008. p.293.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15943/abstract/2\">",
"      Macedo MG, Verbaan D, Fang Y, et al. Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease. Mov Disord 2009; 24:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15943/abstract/3\">",
"      Broussolle E, L&uuml;cking CB, Ginovart N, et al. [18 F]-dopa PET study in patients with juvenile-onset PD and parkin gene mutations. Neurology 2000; 55:877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15943/abstract/4\">",
"      Jankovic J. Treatment of hyperkinetic movement disorders. Lancet Neurol 2009; 8:844.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15943/abstract/5\">",
"      Hendricks AE, Latourelle JC, Lunetta KL, et al. Estimating the probability of de novo HD cases from transmissions of expanded penetrant CAG alleles in the Huntington disease gene from male carriers of high normal alleles (27-35 CAG). Am J Med Genet A 2009; 149A:1375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15943/abstract/6\">",
"      Maat-Kievit A, Losekoot M, Zwinderman K, et al. Predictability of age at onset in Huntington disease in the Dutch population. Medicine (Baltimore) 2002; 81:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15943/abstract/7\">",
"      Adam OR, Jankovic J. Symptomatic treatment of Huntington disease. Neurotherapeutics 2008; 5:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15943/abstract/8\">",
"      Jankovic J, Clarence-Smith K. Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders. Expert Rev Neurother 2011; 11:1509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15943/abstract/9\">",
"      Frank S, Jankovic J. Advances in the pharmacological management of Huntington's disease. Drugs 2010; 70:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15943/abstract/10\">",
"      Walker FO. Huntington's disease. Lancet 2007; 369:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15943/abstract/11\">",
"      Roze E, Saudou F, Caboche J. Pathophysiology of Huntington's disease: from huntingtin functions to potential treatments. Curr Opin Neurol 2008; 21:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15943/abstract/12\">",
"      Jeong H, Then F, Melia TJ Jr, et al. Acetylation targets mutant huntingtin to autophagosomes for degradation. Cell 2009; 137:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15943/abstract/13\">",
"      McNeill A, Birchall D, Hayflick SJ, et al. T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology 2008; 70:1614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15943/abstract/14\">",
"      Schneider SA, Hardy J, Bhatia KP. Syndromes of neurodegeneration with brain iron accumulation (NBIA): an update on clinical presentations, histological and genetic underpinnings, and treatment considerations. Mov Disord 2012; 27:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15943/abstract/15\">",
"      Walker RH, Jung HH, Dobson-Stone C, et al. Neurologic phenotypes associated with acanthocytosis. Neurology 2007; 68:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15943/abstract/16\">",
"      Gregory A, Hayflick SJ. Genetics of neurodegeneration with brain iron accumulation. Curr Neurol Neurosci Rep 2011; 11:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15943/abstract/17\">",
"      Dusek P, Jankovic J, Le W. Iron dysregulation in movement disorders. Neurobiol Dis 2012; 46:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15943/abstract/18\">",
"      Zhou B, Westaway SK, Levinson B, et al. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet 2001; 28:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15943/abstract/19\">",
"      Chinnery PF, Crompton DE, Birchall D, et al. Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation. Brain 2007; 130:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15943/abstract/20\">",
"      Harris ZL, Takahashi Y, Miyajima H, et al. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci U S A 1995; 92:2539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15943/abstract/21\">",
"      Morita H, Ikeda S, Yamamoto K, et al. Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family. Ann Neurol 1995; 37:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15943/abstract/22\">",
"      Kruer MC, Pais&aacute;n-Ruiz C, Boddaert N, et al. Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA). Ann Neurol 2010; 68:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15943/abstract/23\">",
"      Pellecchia MT, Valente EM, Cif L, et al. The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration. Neurology 2005; 64:1810.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15943/abstract/24\">",
"      Hayflick SJ, Westaway SK, Levinson B, et al. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med 2003; 348:33.",
"     </a>",
"    </li>",
"    <li>",
"     Gregory A, Hayflick SJ. Pantothenate kinase-associated neurodegeneration. GeneReviews. www.ncbi.nlm.nih.gov/books/NBK1490/ (Accessed on April 11, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15943/abstract/26\">",
"      Kruer MC, Hiken M, Gregory A, et al. Novel histopathologic findings in molecularly-confirmed pantothenate kinase-associated neurodegeneration. Brain 2011; 134:947.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6231 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-61.234.146.186-4784E7D639-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_36_15943=[""].join("\n");
var outline_f15_36_15943=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H357217\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ANATOMY OF THE BASAL GANGLIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PARKINSON DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      WILSON DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      HUNTINGTON DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Genetics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Clinical features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Future directions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      NEURODEGENERATION WITH BRAIN IRON ACCUMULATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Clinical features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Neuroimaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Pathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H357217\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6231\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6231|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?39/19/40253\" title=\"table 1\">",
"      Classification parkinsonism",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/13/14554?source=related_link\">",
"      Clinical manifestations of Parkinson disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/37/13910?source=related_link\">",
"      Epidemiology and pathogenesis of Wilson disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/6/36970?source=related_link\">",
"      Etiology and pathogenesis of Parkinson disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/37/602?source=related_link\">",
"      Hereditary neuropathies associated with generalized disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/25/8599?source=related_link\">",
"      Huntington disease: Genetics and pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/29/39385?source=related_link\">",
"      Huntington disease: Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/40/18058?source=related_link\">",
"      Hyperkinetic movement disorders in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/63/32762?source=related_link\">",
"      Pharmacologic treatment of Parkinson disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/48/14088?source=related_link\">",
"      Tests used in the diagnosis of Wilson disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/11/23737?source=related_link\">",
"      Treatment of Wilson disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f15_36_15944="Putting on compression stockings PI";
var content_f15_36_15944=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F81922%7EPI%2F53659%7EPI%2F80635&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F81922%7EPI%2F53659%7EPI%2F80635&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Putting on compression stockings",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 421px; height: 437px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAG1AaUDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArO1vWrDRLZZtRn8sOdsaKpZ5D6Ko5J/l3pNZ13TNGQHUryKF2GUi+9I/wDuoMs34A141468UXGoeJbS5srY2lu8Bt42vIwzMwJbIUMCoIPc5O0ZArKrVUF5mtKk5vyPT9G8aWGp6rFp5try0nmDGE3IQCXaMkDa5OcZOCB0NdRXytPqF5Za7a6k80k1zbSLLGen3SDtAHQHGD6g85r6h0+8h1Cwt7y0cPb3EayxsO6kZFRQq+0TuVXpeztYsUUUV0GAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFYviDxLpmghVvZy1y4zHawjfNJ9FHb3OAO5rzTxT8Qb543jnnGkwv9y3tT5l04936L/wABHH96s51Yw3NIUpT2PSvEHijS9DYRXc5ku2GUtYF8yVh67R0HucD3rzrxX8RLzJiWdNIgYfLHHia8cfqqfhu/3hXm8+s3TpIligsYpDlmU75pD6s5zz+Z96zEjALNglmOWYnJY+pJ5NcVTEylojrhhorc2LnXpi8jabD9meTmS5nbzriT6sc/qWrDuRI7mdneW6BDLJIxZsg5Ayeg9qsgUxlyCK522zpSSL14Vu7KO4jHDKGHtXrnwJ1wXehXOjyt++sH3xA94nJI/Jtw9htrx3R5N0dxaP1Q70/3W/8Ar5/Stv4e6sPDvjaynlO2CZvssxJ6I5AB/Bgh+ma0oT5Jozrw54M+lqKKK9U8sKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoorlPE3jO10uaSysE+3amo+aNWxHAexlf+H6DLe2OaUpKKuxxi5OyOg1PUbPSrRrnUbmK2gBxvkbGT2A9SewHJrzPxV4+uJ42FnM2kacePPlX/SZ/ZEOdg+oLey1wuveKpr28a4Nx/aWorlVnYYt7f1ESZ/Xqe7VzUjSzzme5laaduDI/UD0HoPYVw1cS3pE7aWHS1kaN7rdxO8osA1qkh/eTuS9xN7sxyc+5yfpWWkQ3M5yWblmJyzfUnk1IMAe9OAJrkbb3OpJIbtxQKk2HFMKGgYChuKACKSQcUgK+8295DcDoG2v/unj+eDV3WIQy78ZU8H6VTlQSRMp6EEGr1k5u9MAc5lT5H+o7/1oA+hvhrrp8QeELK5mffdwj7PcknnzE4JP+8MN/wACrqK8L+Bmt/YdfutGnOI71d8X/XVAcj8V/wDQK90r1qM+eCZ5daHJNoKKKK1MgooooAKKKKACimTSxwxl5pEjQdWc4ArFufF3h+3YrJrFkzDqscgkP5Lk1UYSl8KuTKcY/E7G7RXKSePtCXiKS8mP+xaSjP4soFV3+IVgPuadqbj1CxD+cgrRYep/KZPE0l9pHZ0Vxg+INgRzpupj6iH/AOOUn/CwrHcB/Zmp49cQ8f8AkSj6vU7C+tUv5jtKK5i18c6FMQJbiW1b/p4hZFH1bG39a37K9tb6LzbK5guYv78MgdfzFRKnKPxKxrGpCfwu5YoooqCwooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACmPLGkTyPIixoCWYsAFA65PavH/G3iV5tc1Gz1KW4S3tXMSWEath1wPncD7+7qM/KBjvk15t/bn2a/lWSF4NImI8ywhwEcrnYXA4Jyee3TrtBrmniVF2sdMcM5K9z1nxd49NxBMNKuTZ6Uo2vfgfvZj6QjsP8AawSf4R0avKL7UJr2E28aG2sck+SCd8mepkbqSepH5k1NeG5vJxcXpG7/AJZxDlYh6D39T/SoVi56VxVKrm9Tsp0lBFcR4UADAHYUgQk1fSL1FP8AKHpWRoU0h9alWOrIjp3l0AVwgpDGPSrOykKUAU3jqF04q+yVCyUAUAvOKXTT5OovGfuTLn/gQ/xH8qlkXBqvdK6oJYgTJGQ647kdvxGR+NAFhp59K1i3vrM4uIJFmiz0LKc4Pseh9jX1LpF/DqulWl/bEmC6iWZM9cMM8+/NfL+oItzaxzRHIYBlPtXrvwM1s3OjXOjzvmayfzIgTyYnJOPwbcPYFa68JO0uXucuKhePN2PTqKK4TxV4zlgupbHRPKMkRKTXLjcEbuqjuR3J4B4wTkD1KdOVR2ieZVqxpR5pHd1n6trOn6QitqF1HCW+6nLO/wDuqMk/gK8Zg1bW9Tu2kfWNQSEMQCkxQyY68LhQPoPxFXDbASNJgtK/35GJZ3+rHk/jXV9TUX7zOCWY3XuR+863UPHk0mV0nT8L2mvG2/iEXJP4lTXP6h4g1u94l1KSFT1S0QRKfoeXH/fVV0h9ak8lfStowhDZHJPEVZ7sxp7WOaTzJ0NxJ/fnYyt+bEmpFRgMKuB6CtQwjsKBB7Vr7Qw5TOWFjTxbtWmsPtTxD7VLqD5TL+zGj7Ma1fJNL5Bpe0DlMY27jkVF9mAm81U2TDpKhKOPow5re8j2oNuvpTVQOUjsPEWtWAxDfvMgHEd2vmqPx4c/99V0emeP4iQms2b2/wD03gzLH+IxuH5Ee9c1JbDHAqrJAR2qJQpz3RvDEVaezPX7C+tdQt1uLG4iuIT0eJww+nHerNeGoJrS4M1lPNaznGZIXKFsdM44YexyK6vRvHl1alYtcg+0RdPtVuuHHu0ff6r+C1zTwjWsHc7qWPhLSeh6PRVTTdSstTg87T7qK4jBwTGwO0+hHUH2PNW65WmnZncmmroKKKKQwoqne6nY2Kk3V1DF7Mwz+Vc3feObVGKWFvLct2bG1aAOworzeTxLr9yxMXk26HoAmSPzqub3XpCSdSkBPpxQB6hRXly3evocrqMzfU5q3b+Itet2HmtFOo6h0x+ooA9GormdL8XWtyfLvUNrL6k5U/jXSRSJKgeJ1dDyGU5BoAdRRRQAUUUUAFFFFABRRRQB5r8X9AMkEXiC0TMlsvlXaj+KHPDf8AJJ/wB0t6CvFtbtcgvjKngivq+4hjuLeWCdFeKRSjo3RlIwQa+dfE2hvoer3WkTFmjjAe2kbrJCfuknuRgqfcZ71wYqnZ86O7C1LrkZh6JcG4tDFKcyw4Uk/wAQ7H/PcGr3lAGudLPpt8swyVXhx6p3/Eda6hSrqGQgqwyCO4rjOsjC0oWpMYoAoAbijFPxRigBuKTFPxSYoAidagdatkVY0TRtS8QzmLRbXz1U7XuHO2GM+79z7KCacU5OyE2oq7MeRAQSav8Ah7w9qniJ9uk2byw5wbl/kgH/AAPv9FBNer+H/hhpdmYp9ZkbU7lcExsNtup9k/i/4ET9BXczzW1hZtLPJFb2sK5LMQqoo/QCuynhG/iOSpi0vhPnLVPD954dupdK1BonkRRNG0WdpR89M88MGX8Kj8GatJ4f8V2d5HHJKqlopoohlnibr+RCtz6V1fj/AFK28T6vbT6eksMdvG0RnYYaZSQRhSOACDgnn5jx3qrpOnRwJiNAueSe7H1J7130crcZ89R2XbqebiM3jyclNXffobPinx7qtxbz/wBnr/Z1qqltykNMwA9ei/hk+jVz6QvZ6HLIxLPFCWJJySQMkn8am8SxLHps2B/Ac/TFaU1t9p0meEf8tI2T8xivZjywiuVWVzwZznUk3J3KOgWwiSOIdEUL+VbskXHFYuhziRIZenmKrfmK6XaCBWdVtS1CC0KSxGpFiqyIxUqR5rJyLUSqIfanCGrohpwiFTzFcpTEWKXYBVox4qNhilcTViHaKNop9FMQ3bQVp+KMUXAgdOKrSR1fIqKReKaYNGRPFms+Zdua2p0rOukyDW8JGbRn6T9pj1pJ7CWWCaMZZ4jgsP7p9R7GusGu61FnN6x9iinH6VieGgFu7on+6B+tX77cpJXBrixkm6lux7GBilSv3HzeJdcJIF6wHsij+lULvV9TuB++v5yPQOQP0qtLI5JGKYq92PPpXKdgtvbNNLukJPqTW1B5MWEjUvJ6KM1QsEe6cpGdkQ+84/kK3LaBLdAIxgfzoAZHDdSdkjHvyakFsFGGkZm9hWjaxtOeBWhFYxpy/JoAyra0yvG41LJYkg9RV6W8jiYxwruf27VCRc3B+9tHsKAMeXT3DEkK6/rS6ff3Wjz5gYtBnLRN0I9vQ1py2UhGWndfyqpOluBtknVm96AO00rUbfU7UT2zZHRlPVT6GrleZaTfHRdV86Nw1tJ8sij09a9LikWWJZIzlWGQaAHUUUUAFFFFABRRRQAVxXxU0F9V0IXtnD5l/p5MqhRlpI/40H1GCB6qK7WipnFSVmVGTi7o+U9VhWeFJ4SGUjII7im+HrvhrOQ4KfNF7r6fh/LFdp4/0BdB8RSwRLtsb7dcWwxwhz86D6E5A9GA7V55ewyWl0ssY+dG3L7+34jivIlFxbiz1YyUldHVYoqK0uEureOaI5Vxn3FTVJQlJTqTFACUsCTXN0trZQS3V2/KwQruYj1PoPc4A9a2fC3hjUfFB8yzYW2nK217x1zu9REv8R9zwPcgivZPDnh/TvD1l9n0yAJu5klbmSVv7zt3P6Dtiuilh3PV6Iwq4hQ0WrOJ8LfDUApdeJ5EnfqtjET5S/77dXPtwv1616RbW8NrBHBbRRwwxjakcahVUegA4FSVU1S/t9L06e9vH2QQruY4yT6ADuScADuTXo06Sj7sUefUqOXvSZBr2s2eiWLXN6+M8RxLy8rf3VHc/oOpwK8k1jVdQ8Q3Qlv22wqcxWqE+XH6H/ab/aP4Ypuo39xreqSX95kM3yxRE5EKZ4Ue/qe59sYtW0AAHFetSpKirvc8LEYmVZ8sfhK9vaAYJFaMEWOMVYityR0qdYcUSncwUTE1+18+zePs6lfzGKsaJL9p0qCQjDMgJHoccj86u38O+AgVkeH3NvPdWbkYDeag/wBlsk/+Pbv0pp80PQW0jLs5DBezQEYMUrKPofmH6ED8K7C0bzIQa5LXIjba1FOOEnHln/eGSP03fkK6HSJwV25qqy5oqSFDR2NZFyasogAqCNqmWQYrlZ0xsSYFITimNJUTSUrDbJWIxVZzzSs+ajJzTSIbuFPUZplPSmyUSqlKY6elSAZqbmiRUZKiZavtHxVaVcU0yZRKEy8VmXScGtiQVnXS8GtoMykjO0KRY9Rmjc43rkZ9q2b6Jc53AZ965HUXeG5iljOHDjH511NxbmaNT5u0Y7LWGMhaSl3PTy+pzQcOxmzukYPIwO5qGC3kuW3uGjg9TwW+lWY47aOXLhpXXoXOR+VWJmeYgnhe1cZ3lm2kjjRVjAVR0ArVtY/OcZHy1k6fZtK+ScIK3FkEICr2oA2YQkMfAAArPuLt7hykJIj6Fh3+lVrq7NyRbxkhR98j+VW7OLb16CgCSztAvLCrc8yW8eWIHammQDIHbrWTIz3VxuP3F4Uf1oAS8kkuW5JCdlHeq32TC52qo+laojEMW+TsKrRK9wxcjC9hQBi3tgHRiAQcdQOtdR8Pb+S506a2nJMls20Z/u1hardbGFrAA82OfRR71o+AGAvb1T99kU8d6AO3ooooAKKKKACiiigAooooA57x34eXxHoElshVb2I+dayH+GQA4B9iCVPsa+fL+Ez2xLRtHKuQ6N1RgcFT7ggivqSvGfinoP8AZeujUoExY6icS4HEc+P0Dj/x4H1rjxVO650deFqWfIzzDQbg2941s/EcuWX2buPx6/nXR1zWsWhjfehKnOVYfwnsa1tN1BLmwE0pCMnyyD0b/P8AOuA7i67rGjO7BVUZJJ4Ars/BPgWXWlS/16KSDTDhorU5V7ger91T/Z6nvgcHQ8AeBmmaLV/EMJAGHtrGRcbfR5Qf4vRT0789PUa7aGG+1M462I+zAZDFHDEkUKLHEihVRRgKB0AHYU+iiu44gry/4mao17q8WlRODb2m2SYD+KUjKg/RSD9WHpXpV7cx2dnPdTnbDDG0jn0VRk/oK8NtWlu5ZLm5/wCPidzNJ/vMckfQZwPYV2YOGrm+h5+Pq8sVBdS5aRdK27SHpVSzhyRxW5bRYArepI8+ERY4gBQ6AVbCgCq01YJmzVkV3QEGuW1rFhew3q8CM7ZP+ubEZP4HB+gNdSxrF16DzoGGA2RyD3FbUnaWphUWmhFrdr9u01jGMyKA6f7w5H6is7R7wOsbKThgCM9aseGrsS2jWkhPm2/yHcckr/Cfy/UGsq5iaw1WRACIpSZY/QH+If1/E+ldEY7wZk3tJHbQy7lBqTzKxtMugyAE1pE5GRXNKNnY2Urljfmms3FVjJiqF3fPC/T5aFBvYTkM1DV1sblEmbarttUn1rRt7gSfjXL68YdStHQkBscHuD60eGdQea3Ecp/fxHY/v71u6ScLrczU/esdnmnJVeB9y1YXrXM0bIspU6VXQ1OpqGaxHt0qrMKtE8VXmpIctijJ0NZ930NaUnesy96GtobnPI5jWF3Icda6/TQLnS4HZhkoCfyrl75NyGuj8Np9o0eBSegwfwp4xXppnVlztOS8iOeKJGJXBaltoHmbLn5RVya08puE3D1qCSR0GAMCvNPXLXnrbx7VpiXGY3kbsOB6ntVRcN9409f3kqon3U5P17UAaOnQFZASck8k+9bLMI4yap6chC7mourhQWZ22xIMkmgBl/d+Uixg/vJevsKsadhgHI4HArmIbhry6knJPznCg9l7V0tq6xwYzjAoAkvH8+VYlPHejUJ1sbCSXgBF4Hqar2zZnLZrL8VTmae1s0PU72+goAqWn+raR8mWT5nY1u/D35tSvCedqAfrWDrL/Y/skSYDSAlvpXT/AA3tyLe7uT/G2BQB2dFFFABRRRQAUUUUAFFFFABWd4i0mHXNEvNOuMBZ0IVsZ2MOVYe4IB/CtGik1fRgnbVHzHqNrNG1xZ3sYjvLZzFMg6Bh3HseCD6EUvwzuNP0zx3ZnWIVkgkby4mc/LFMSNjkdD3GT0yD2r0n4w6EkTw+IIFIyVtrwAcYJwkh+hO0+zD0ryDWbPcCwH1ry5RdGoepCSqwPrGiuL+FPif/AISTwxGLiTdqNliC5yeW4+V/+BD9QfSu0r04yUldHmSi4uzCiiiqEc38RpjD4O1AD/lr5cB9w8iqf0Y15tYJk16D8TwT4Tkx0FxBn/v4tcHp+M16OG0pfP8AyPHx/wDFS8v8zas06VrwjArMteAK0I24qJmcNCZzVaQg55qSRs1WkI59alFSYx+O9U7kBkOaparey2fzxxNMoPzBOoHqB3+lV7fU4b2PdDIGGcH2PoR2rdU3a5hKS2MDUGbTNVS8jBCDiQeqd/y6/n61ravGupWQaBlEqkPG3bP+B6fQ0mo2y3ETdzWNpMz2cv2OQ4T/AJZZ9P7v4dvb6V1L3kpLdGOzsXNLu8qMgqc4KnqpHUGuktbgMoBNcrfR/Z5jcxjMbf60Dt/tD+tXLW72Ec5B6GpqQUtUOMraHRTLkZFUZ1Djawp8FzuXrxTZmBORWKTRb1OS13TZ4Xa4tHI7lexrM8Paoqa5GJMxvKNjKe5HIP8AOu6lUSRlT3rzzxVaG1uFuYRteNgwIruoyVRckjCa5feR6taNkA54q6DWB4evlvdNgnU8MoNbkbZANedUi07M6Yu6LUZqdDVRDzU6msmaxZOTxUMh4pxNROeKSKbK8nes29HBrSeqF0Mqa1huYyOfusAEGt3wrciKxxjIDstYl3GWJqfQm4ubckjDCQEdef8A9VXiVeka4GVq1u51kl5G6kbMVlTNvc4HFNIuVHy+W49TwacsdzIpzsQf7I5/OvLPbGDapA6uegq9YwbBjqxOSfU1TtLfy2JbPuTWjCXZtsY/GgC8ZAF8tPxrnNfvBM/2SFvkXmU+p9KvatepYwmGFg1047/wj1Nc7awknGScnJJ7n1oA1NOTYoY/hWnPP5Vv7mqMQIZE/OpLxskL6UAaGkMXTcayf+PvX7lwchXEQ/Dr/OtrTECW9YmiMqG4uZSAgZ5ST9TQBR8SzCTWxEhz5SBfxr1Lwra/ZNEt0K4ZhuP415H4ZU6x4nSSYHbPPux/s/8A6hXuQAUADgDgUAFFFFABRRRQAUUUUAFFFFABRRRQBBfWkF/ZT2l3EstvOhjkRujKRgivnfXNIn0fUrvSrzc7wH93I3/LWI/cf8RwfcGvo+uA+LegNe6ZHrNoha709WMqqOZIDyw9yuNw/wCBDvXPiafPG63R0YepySs9meQ+DNck8JeLbe8LEWUhEN0ueDGT976qfm/AjvX04jrIiujBkYZDA5BHrXy1qUC3EG9MHjII7ivVvgh4n+3aW2g3jk3dguYCx+/BnAH1UkL9CvvWGFqW9xmuKp399HqFFFFd5xHO/EKEy+DtSxz5SpOfpG6uf0WvLrOQiYc17VqVqt9p11aSfcuInib6MCP614bYs+2IyjEmAHHow4I/PNejhHeDj/X9aHk5hG04yOutT8oq4jis2zfKCrYNTJanMmWWcYqpNlgQDTiabjnNJaDbuYl9pTXMm9p7hOMYjlKj9Kybnwxuk82K6uo5R/EH5P1712JGaYyZreNaUdjJwTOMFprNmCBLFdRjp5gKt+Y4rN1CYSDbeW81rIOd5GVB9Qwr0IxZqtPZRyqQyitI11e7RLp9jjdO1ISAQ3DL5g+64PDj1H+FE2bZiwG62PJ29Y//ALH+Vat94XtpjuRdjZzlTjms6XS7+14jkEqDs45/Mf4VupwlszNqS3LNvcFVBVsqeQQetWRc7uprnJpn04b2jdIwcshGVP0I6VbtNRtLxN0EoB/utwaJU+vQal0N+OTPesbxJbrLASRmrEcpXvmmX8gkgOamC5ZXG9UVfh7cbLW5tHPzRSHaPY//AF812dlcBpWiPUDIry/S7sWXiMEP8rphsGu/hk2XMMo+6Tg/Q0Ymn71+4qUtLHRKeanQ1VBqaOvPZ1IsZ4qJ6duwKjds0htkT9KqXHQ1ac1QumxWkUZsz5VBaqtus0WpzTRJuggtzLOf7q7gB+OT+h9KsSyqivJIwVFBZiewFdbZaLLZ+Adbmuoyt5e20kxjI5jUIdiH3HU+hY1rOSUbS66F4eEpTvHpqY8MwIV4mDxtyCORV+O6AXBA/AV57pRu7eSRLWcqPvBW5BBre025u7i3ZpZAro5Vti1x18K6Wqd0elh8ZGs+W1mdGhj2tJMyog7scVn3+tqiGKwUkngykcfh601YklXLhpG9XOacNOB+biuU7DGihklcu+4knJLHJNbVlaiNPMkGPQVct7SOBd8nPtU0cD3MuQMIKAG2VvvZpCOKozAvcEe9dHJGsNqwHYVg2UfmXJJ6ZoA0Yzsi29tpzXnz6hPcWwtIlKRtw7d256fSvQrnEcMx9Iyf0rhdOgHkq7DkjNAG98PLb/ioYDjhFY/pXrVcR8PLAh571lwuPLQ+vr/Su3oAKKKKACiiigAooooAKKKKACiiigAoIBBBGQaKKAPn3xhoZ8PeIbiwVNtnKDPZkdPLJ5T/AICePoV9a5rTtRufDWvWuq2I3SQtkp2kQ8Mh+o/XB7V798RvD/8Ab3h6QwJnULTM9sQOWYDlPowyPrg9q8HnjS6tw6chhkcc15laDpTuj0qM1UhZn0tpWoW+q6bbX9k/mW1xGJI29iO/v7Vbrxn4H+IRa3Vx4cvHIWUmez3Hjd1eMfX7wH+9Xs1d9KfPHmOCpDklYK8Y8VWJ07xNqEIGI3l+0R+6yfMf/H94/CvZ68g+KmvaSPFen2UM4e/EbRXGwgqmTlFY9mzu4/2ue1duFqKE7PqcGNpOpSuumounSfIvNainIrlNPutsm0nvXQ20wIHNddSFmeRF3RbopucjilArIsWiiigBwXNKY6dH1qYLSuUlcptH7VG0QI5FaYiB7U1oPajmHyMwLvT4plIZRXI6z4RhdmktMQSew+U/UV6M8OO1VZogQeK3p15QejMZ009zxqeO60+Xyrwywg9HRjtNW49ONym77RJID2LGu/1bTY7uB45I1ZWHQiuB1OwutBmEkbM1oxxz/DXo06yqLTRnNKHL6GXPAtjqVsygAB8E+x4r0XS28208pj86Db+HY155rMnnQCVTnoeK7XT5ykVrc/wuoDfQ0YhNxT6hT0bOu02fzrcbvvr8rD3q/Eea5+OQ29wJh/q34b/GtyJwyhlPBry5xtqdcWWWFMdcU9DuWnEZWsjW1yq3Q1k37hQzMQqjkk9q15eAaw7aSG88Y6TYXADWrz5mz0OFYqp9iwUY79O9bU1e77GbV2o9zd8G+HJNRmh1HUYilghEkETjDTMOQ5HZR1APJODwOvf6nH52m3cf9+F1/NTVmoL51isriRyAqxsxPsBXDOq6krntUqMaUOVHgGnM32O1uj1CgP8ATv8A41uaevkXkmD+7nGfxrK0JQbaO3f+OJSAfXHNaFmSjG2c4kTlCe4r1a8edOJ4VCfs5KR0EHlRj5yKsNdQqmU5NYaXEUrCG5Ply9Bno30NalrZxJgsxYV48oODsz6CFSNRXiyS3El1IBztrZ+S2hCjrVeB44h8oAFR5a6m/wBgVJY/UJyLM+pFQ6PAQnmP3ouP386xLyoq5M6W8O1cdO1AGZrsuyxvZAeBGQKw9CsJr64gtolJJwGP90dzWxcW0mriPT4DteeVQzEZCqDlj+Q/Wu70bSLbSbcR265c/ekPVqALVhaRWVpHbwDCIMfX3qeiigAooooAKKKKACiiigAooooAKKKKACiiigArxL4k+HzoviBrq3TGn6kxkXHSOfq6/wDAuWHvur22sbxdoUXiLQbiwkby5Dh4Zf8AnnIvKt9M9fUEjvWVan7SNjWjU9nK583X3nWlzDeWTmK4hdZY3H8LA5Br6R8H67D4k8O2epQ7VaVcSxg58uQcMv4H9MHvXz5PFIRJDcxmK4iZopoz/A6nDD86s+DfF954Olv7eCPzob0YjVj8sU/AVz7Y4I74WuHD1fZytLY7K9L2iutz1L4meM30uKTSNEkH9rOoMkoGRbIe/wDvnsPxPYH5x1SznhnMhZy5bcXJJJOc5J9feu7UNud5ZHlmlYySyuctIx6sfeq19aJcRkEc1NStKcuYunRjCPKWvD+oLqWnpOp/fphZV9G9foa6fTrjIwx5ry2I3GiX/wBotuR0dD0cehrudL1CC/txcWjZ/vIeqH0NfS4TFRxVPX4lufJ47Byws9Phe3+R2EUvFWVfNYNpd5GD1rRhmBxzVyg0cqZoA0VCkmalBzWZQ9SQatwnPWqoFWITipZcS4qipAgIqBWqVHqDdMbLDxVGWLmthcMtVbiLFCYThdXMaaLisTV7RJ7d45FBUiunkUYOayNQXKmt6crM5Zx0PINb09rAyIg3QnPH92ur8OAXnh2DHJVcflxUXiSD5SSKZ4Emxp8kfZJWXH6/1r1Jyc6V+qOSKtKx0mlS+bGbab76jjPcVbt53sH2SAtD2P8AdqpLAQVlhOHHIq7bSrdx7XGHHBU9q4pW36G6Ni3lVlDKcqatjkVz/ly2h3Qcr1KH+laen3i3AI6MOoPUVzyj1RtCXRhfHZG7egrjrV/KnbUnyPJmW4yOuEYN/wCy12Opo00DovBIxWOtgsVmYnGQRtPvWtKSitTOafNoexghgCDkHuK57x/dfZPB+psDhpYvs6+xkITP4bs/hVrwhcNc+FtKlkOZPsyK59WAw36g1zXxbuSum6bag/6253sPVUU/+zMtcNGH75R7P8j2q1S1FzXb8zz8o0flyoMFTkVqXUIvLeO4tziQcg0sdr5tkCBziotLkNtdGCXiNzxnsfSvScr6rdHhJWI1Md9EYLldsy/5yKs2V5cWX7u5JkjHCuOoHvVvUdMWYCWLKyDkEVRikYSCG7XDHgPjg1ElGpGxrTqToyujTWT7Rh45QyexqZrySNfLiyB3JrBvrZ4R5kLMjeqnFbXgCH+1NVnt9QLSokBcc4wdygdPxrjnhuWLknoelRxqqSUGtS3azKgzuLOetTr5lywVEZ3PQAV1SeG9OVs+W59i5xWnb2sFsuIIkQewrlO4yfDmkvZb57kDz3GABztX/GtyiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAPJPi7ohs9Sh1u3jAtrrEF0VH3ZOiOfqPlz6hfWvLdZgHlO5+UAElvT3r6Z8VWsV74a1S3niEsb20gKHudpx+uK+UrXU7YxxG+jvZdoBwZA659SOM/jmvOxUFGV11PQw03KNn0OpsneSzgeYYkaNSw9CRzU1Z9vrOnz4C3KKx7SfIf1q+rBgCpBHqK5TpILq1SdCCBmsMwXOmXP2iyYow6jsw9CO4rpKZJGsikECqp1JU5KUHZkVKcakXGaumLpOuw32Ekxb3PTyyeGP+ye/wBOtdDbXJB5NcFqGlbslBTrDWbzTiIr1GuIBxu/jUf1/H86+gw2ZwqrlraPv0/4B85i8onTfNQ1Xbr/AME9Ot7jPer8Uma5TRdRttQj32kyuR95ejL9RW5DIRXdKK6HkptaM2EcVMrVmpLTxP71k4mikaiye9Sq9ZSz1Mk3vUuJama8UlSP8wrNjlq0kvFZtGsZ3GzQ9ax7+PANbUkuRWVfHdmrg9SKlrHE+IoswucdqwPBrFLm+hzzuDj8f/1V2OsRB4HHtXBaRP8AY/FCK3CTAx/j1H8v1r1aPvU2jz56STPRdNlWYMjfeXjFT3FllhJEdrjuKy4y0M4kjGSOo9RXQWc6TorKcjv7VxzvF3RvHXRleK6ljwlxCzdtyjNaEEUe/eqgMe+KkMCuMipYYttYykuhrGLBgM81nXzqM8gAVfuDtBrkteujKZYF3eWqkyleu3HIHuaqlDmYqjsep+Bo2j8J6dvBBkQygHsHYsP0YVgfFXT55raw1CJGeG0MizBRkorbTv8AoNnPpnPQGu4tzE1vEbcqYSoKFem3HGPbFSHnrXHGq41PaWPYlRU6Xs7nlOm7WtUK4IIplxYrK4OB610uq+F5bKSS40RVe2bLPZE4Kn/pken/AAE4HoR0rndK1Oz1W3E9hcJMnfHVfYjqPxrqU7+9E8mpRlTdpIu26lU2t2pJrVJBnaM08N61L5i7feldgrNGNfxbIiDWl8M1zr9+f7tsg/Nz/hVO/wCVNbPw1gK6hq0pHBigQfgZCf5iqm/3UisMr14/10O8ooorzj2wooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigBk0YlheNvuupU/jXyLfaRd6THHFq9jdWTqApaeJkUn2YjB/A19e1wXxui+0eAp4M48y4gX/yIK58RTU437G+HqOMrdz52NmkiZUhh7VALaS3fNvJJEfVGK/yo1PRpdP2tDMQT6HFeweHPhXb6z4R0nUYNWu7a8ubZJXEiLLHkjPA4P/j1cEKbn8J3TqKHxHlcOpapCMecsoH/AD0QH+WKtQ+IpUOLq0yP70Tf0P8AjXcan8LPElmGNvHZajGOnky+W5/4C+B/48a4/UtA1OwDnUNJ1C0ReryW7bB/wPG39aJU5R3Q41Iy2ZPb69YS8PL5R9JVK/r0q2Ut7qPcjI6nupBFct9ljlGYnRx6g5qFtPeNt8W5G/vIcH9KzLN+bSXilE9jK8My8hlODVu18XajZOItShjlxx5mNpP1xx+lcqt5qlqfkupWHpJ8386n/t6SRdt/ZRyj+8h2n9c11UMXVoaRenbocuIwVHEfGte/U9GsvEou4Q8UQPqA/Iq5FrBY/NCw+nNeSDUY7ecTWLzQP6MP044IrqdE8WWs7LHe7IZf74PyH/Cvfw2Oo4jRq0u3+R83i8trYf3o+9H+tzvY9UgONzFT/tDFXYLyN/uuD9DWLbSQXEYaN0dD0IOQamFpG3ICg+o4rqlCJ56bOhjmHY1YSY1gW6vDwGYj3Oa0IZSevWsZQNFI1BJkVVuTkGhH4ok+ZahKxbdzGvV3AivOPEts9tcieMfPE4cfga9PuU5rl/EVkJ4JAVySDiu7DVOWRzVI3RPa3Jnso7mHkMoYVqwB1Cz2x4YZI7GuN8FXZVbjTpj88Z3ID3U9f1/nXW6ROI5XtpDgE5TP8qK0OVtBB3RuWN+HO1vlcdVNaccgYVjPao+D37Edav22VUAkmuKSW6OmEmtGJfP8rH0Fc9Yw+ZvlPViWrobtPMjYDqRis+2gMFsVbqBVwlZETV5HTfDW8drS8012LJZsrQ5/hjfOF/Aq2PQYHauzrzv4YPnW9bHcw2/6NL/jXolceJVqj/roexg5OVGLf9ahXzd4i8Py6V4v1ZNNmktZorhmRozj5Hw4HuAGx+FfSNeW/FOz+z+ILG/RfluYDC5xwGRsj8SHP/fNcGJcow54OzR6WFUZT5Jq6Zx9hrXiONQs0drc46syFWP4g4/SrFx4s1G2U+bom8juk5/+IrU08I0QOBmtP7NHInKiueGY10tbP5GtTKcK3pG3zOBvPHGoOreXoyxe8kpYfyFe4eB9PFnokNw0jPPeolxJxhVJQfKo9B7k9TXjfjWBIrWQoAMKf5V7zoqeXo9gh6rbxj/x0V1UMZUr3Utjnr4CjhuWVNau5cooorYxCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACuH+MRx4QQet5B/6FXcVwnxkP/FKQD1vYf61nW+BmlL40eGeIgCYye1fR/gBPL8C+HV7jTrfP18ta+a/ExIK47Cvp7wmnleFtGj/ALtlCv5IK5MHuzqxeyNWiiub8a+LLXwzZjcouNQmB8i1DYLf7TH+FB3P4DJrulJRV2cSTk7Iz/H9p4Qs7E3niLTLWWaQ7YhHGBcTN/dUjB/HIA7kV8/mxn1LXfsmhRSrLcSHybNWMojX0LNycDksSBW/LNrfjfxKYrf/AEvUpFw0gG2G2jz267UH4kn1Ne3eB/Bth4Tsitv+/v5QPtF04+Zz6D+6voPzyea4uV4iV0rI7Ob2EbN3Z5Tc/CXxLFEGWbTLs7QWRJGRs9wNy4I9yRXJ6t4T1fTC39paNfQKOsgj8xB/wJMqPxNfVNFaSwkHsZxxU1ufG5sopQTFIjj2Oao3WnMoyq5r6+1jwzomsEnU9Ks7iQ/8tGiG8fRhyPzry34pfD3S9C8L3er6IbuKaB4x5DS+ZGQzqv8AEC38XrWE8NKKumbwxMZOzR4bbXN3pzhoJHUZyVycH8K7nw1rSaniISvDdKMmMtw3utcVeS3KKDcwfL6gEVJp2latcW51TSbC9lggkwZoYi4jYAHnGccEda6sHmFWi1GWsfy9DkxuXUsQnKOkvz9T1yA3agFJd3s3NX7W9fOJ02n1HSsPwtqn9p6fHOV2yAmOVP7rjrXRNErryK99yjJX6M+WcXFuL3RfikDAEGrCnIrPt1MYAzxVyNqxki0MnTIrJv4N8bCtt+RVCdOTTg7CkjzLWFk03UFvLcYkjOSP7y9wa6uzuYtUsIru2JBPX1U1B4msldA+OvFYfgy5NjrUumuw2zguq+jD/EZ/IV6Mmp0+bqjnSalY9C0jUBJtiuOJRxns1bqrkcVzwshKuQMN1GO1WrK6uIpRDMu9ezjr+NedOKesTphK2jNcg5qCZDtIqwjg/WluACvFZXNWroo+CpPsfjJUJAW6heLHqww4/RX/ADr0+vJ0Hk+INJmQfOLuJR9Gbaf0Y16xWeK1al5HdgH7jXZhXG/Fe2abwobhOTaTpMRj+E5Q/kHJ/Cuyqpq9imp6VeWMvEdzC8LH0DAjP61xzjzRcT0acuSSl2PHNEkDx10MX3a4/wAMyP5YWYbZRw6+jDgj88110H3RXiR00Pdnvc474gfLp859I2/ka98tk8u3iT+6gH6V4T49j8zTZx6xsP0Ne9V3YH7RwY96Q+YUUUV3nnBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXBfGY/wDFMWY9b+L+TV3tcB8Zz/xTenj11CP/ANAkrKt/DZpR+NHhXifofZCf0r6p0hPK0qyj/uwov5KK+U/FBbLKO6MB+Ve3eO/Hq6ckulaBIjXcQ2T3fDJb+qqP4n9ug75PFcmGmoKUmdeJg5uKRqePPHNvoEclnp5judXI+5nKW4P8Un8wvU+w5rx/R9K1fxvrcsVrNLIzHN5qEwLBR6E+v91Bj8BzU/hLwrqPjS8Zo2kt9JSUm4vJCS8rZ+baT95z3J4Hf0r6A0TSbLRNNisdMgWC2iHCr1J7knqSe5NaKMq75paIzco0Fyx1ZU8K+G9P8MaYtnpsWM4Msz8ySt/eY9/p0HatmiiutJJWRyttu7CiiimIK5v4kQfaPAeuKBkpavMB7p84/wDQa6Sq2p2wvdNu7U4xPE8Rz/tAj+tKSumhxdmmfM+rRrLZscAjGRXoH7O0qraa7argBJIZcf7wYf8AsleexsZdGhZhyYlyPQ4rrv2fbjb4j1e3z/rLVXx/uPj/ANnrzMM7VEeliFemzsfiTYizvoNX2qIJUW3nOPusCSjH67mBPstYFtIkiBlYEH0NemeK9LOs+Hr2xTb5siboi3TepDLn2yBXjVtaMw3RNJC2SGToVYHBBHqCCDX02HanTs3qj5PGw5KnMtmdGpHrUqsB3rFitrwD/Xn8QKsRwXQbLSlvrVuK7nKmaqtmopl4p0KlVAJ5rO1zXNP0mM/bJ180j5YU+Z2+g/qeKjYtJy0Rm+J5IrbTZLidgscfJJ7+31ryvT11B71dVtlLTLJ5g7556fSuo1L7f4luRJeIbewTmODPX3PqaZ4QAjgML/eicofqDivIx2Y3tCk/hd/mfS5ZlXLFyrrWStbyOx0TxfpV5Gi3My2Nzj5org7MH2Y8GujiurSUB47iBx6q4Ned+I9KhurKVhEhlA3K2O9LpnhjS7uG2u4VdEmQNt3fdPcfgciiGaxavOP3GVXIWn7k9PNHoj31pCMyXUCD1aQD+tU7nxPolvGTLqtocdklDn8lya5//hBdPk+b5j9TU48I6daxFlgUsBwTzTlmcOkfx/4AoZI7+9P8P+Cdd4KgXxFeWmsQJ/xLIHZkkcgGWQZUYXqADk84OQOCOa9Irzv4QTiKPWNN6eVKlyg9FdduB+MZP/Aq9ErRVnXipgsMsM3TQUUUUDPFtStBYeNdZtwMIbjzl9xIoc/+PMw/CtuH7o+lVviHiHx1EV6yWcTEe++QZ/ICpoGygPtXj1VapJHt03zUovyOd8YjdbMv97j869zrwrxacxfRh/Ovda6sFtI5Mf8AZCiiiu488KKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK8++NJ/4p/Sx66in/oqWvQa88+Nf/ID0f31Jf8A0RNWVb+GzWj8aPCPFDAuy99mK7j4c+B7jxVBDc35ktNCj4Gz5XuT32nsvq3foPUcpcQJc+ILKGRVdJJ4kZWGQQZFGD+dfVcaJFGscaqkagKqqMAAdABXHhqSm7vodeIquCsupFY2dvYWcNpZQpDbQqEjjQYCgdqnoor0TzwooooAKKKKACiiigD5qvbf7PcajaYx9nup4QPZZGA/QCrvwTm+z/EQIePOtZov1Rv/AGSrPjCD7P4y1+HGB9pEg998aN/MmsX4cTi2+J2kNnAM7xn/AIFE6/zIryo+7Vt5npy96l8j6Zrmdc8I22o3cl5aztaXUg+fCBo3P95l4OcdwR75rpqK9eE5Qd4nkzpxqK0lc8K8X6nqPhPWv7OuLNL7MKzJNFmMMCSOh3Y5U96wZPG+qvxbaOise7uW/kBXV/F3XtOutf061tB5s1qzwXE4I2KXxiP/AGmDKM/3c46k45y2CrIMiuOvmVWE2o2O3DZRhqkFKSf3lOS68UaxhfOFpGeogGz9eT+ta2geC7a2k+0XRaec8lnOea07JgMVuW7ZAxXHUxVWtpOWh3U8JRw/8ONjH1aySNAUGAK4S1T7L4gvIjwshEq/j1/UGvUNRjDwGvMvEI+za/ZzjhXBib6g5H8zXO10OuEtLnUoqyw4PIIxWd4dkNpc3enP0jfzos/3WPP68/8AAqv2PMa/SqGsYstTsb7GF3eRK3ord/oDtP4Uo9hz01O4sn3Rippl3RkVm6ZJ8u0npWp1FWjB6Mp+B3+yeOI13YW5gkhI/vMMOPyCv+derV4xqMw0zU7DUc7Ra3Mcrt6JnD/+OFq9nr0cHK8LdjzsbG01LuFFFFdZxnlXxVXZ4t0iT/npauv/AHy4/wDi6dGdsQ+lO+Lo/wCKi8OY7xXI/wDHoajVSYR9K8nEfxWexh/4Mfmc54oOLOVz0X5vy5r3ivDPEFv9r066t1+88bIPxGK9m0W9XUtHsb2MgrcQJKP+BKDW+BfxIwx6+Fl2iiiu884KKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK86+NZ/4lGir66jn/AMgTV6LXnHxrP/Ev0Mf9PxP/AJBkrKv/AA2a0f4iPJLEK3i7SA5Chr+2XJOOPOTP6V9RV8lXEsMOrzi+hjkL48suARtwOBn3zmuq8O+KdR0rC6TqcqRD/l1n/exfQBuVHspFcVCsqejOyvRdTVH0XRXl+j/FJ02pr2mMB3uLE71+pjPzD8C1d5oniDSdcjLaVfwXJUZZFbDp/vIfmH4iu6FWE/hZwzpyhujUooorQgKKKKACiiigDxb4ow+T41mYDia0il/HLr/JBXnGgzG18eaTLyAuoQZ+hkUH9Ca9T+MUPl+JtLm7T2cif98Op/8AaleTXbiy162us/6qZJf++WB/pXl1fdqs9OlrSR9bV5l8TPHX2MT6Ros+y4X5bq7Q/wCoB/gT/pp7/wAOfXpL8SvHP2DzdJ0WYLeAYurlefs4I+6v/TQ/oOeuK838EeFbjxpfGNC9rols2J51PzO3XapPVjnJJ6ZyckiuqtVbfs6e5y0qSS9pPYg8I+DdQ8a3DPbObLSrYlftDDOXHIVfU5xk9vrxU8JfOJUMcqkpIh/hcHDL+BBFfQ2mWFrpenwWNhCsNrAgSONegH+e9eRfETSv7M8UzSxriC/X7SnoHGBIPzKt9XNc+Iw/JTUlujswmJ5qji9mUrVsqMVs2T9Aa5/T3yMVs2zYIriR2zRqTLviI9q848d25WyMwHMEiyD88H9Ca9IQ7lrlfFlmJ7W4hI4lRl/MVT0aZMOqKmiT+bbxkdCBVnW7VbywlgfpIpWsPwfMZNNgLcMFwR6GupmXfBU7Gr11KfhO+a80y1mmyJtoSUHrvHU/jwfoa62M5UVxmnt9nMWFAV5JIXI7SIdyg/WJ4/8Avg11lm+6IGtGrM573Vylr9ss9pIrjKOpUj2NeieCb9tT8KaZcyNum8kRyn1kT5H/APHlNcReqJIGUda1vhTcbbbVNPZgTDOJ0X+6kg/+KRz+NdODlabj3OXGRvTUux3lFFFekeYeXfFRvM8XaDF/zzglb/vpk/8Aiam8siNR7VD8RVDeOtMz0+x8f99mtTaDGv0ry6yvVkerRdqUf66nM3kB804rrPhfdlbG80qRgWtJfMiHfypCWH5MHH0xWNfRYcNiq2j3J0nxXpt0DiKZ/sc3ushAX8Q4T8CfWpw8uSp6lYiPtKT8j1miiivWPICiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACvNvjWf9E0Mf8AT25/8hP/AI16TXmfxrP7vQR/08SH/wAhmsa/8NmtD+IjzDw7bQ3/AMQ9FtLqGOeB5/njkUMrDaxIIPBHFeo+Kvhr4YnkDW07aNduCVEDZQ+p8s9hn+HbXnHgBfN+LGjKegeQ/lDIf6V7bePeJf3UEVvMtxeSiFLsKNkMITOc9c534GPvHngiuahFOnqup015NT0fQ8c1TwL4p0iP7RYrFrNiRuWWzbcxX12Hn/vktXNHU1hvRHqFtLa3sXTcpjljP6MtfQF/I6sP7ON3HYWGLVBbuoBl4ALA9UXIB685yOOZ/E9tpl9BZwa7p9tfwOjPJJsLGIBc7lwCwGTjIIxmiWHi9nYUa8tmrnk2heOdb0/AtdUF9D/zxv8AMh/B87/zJ+ld9o3xO064Kx6xa3GnSnrIB50P/fSjI/4EoFc7qvwfs722S98M31xYGRA6294pdeeQM/eX8d1cbrHhjxV4bUte6fJc2yDme1/fJj1OPmA9yBQnWpeaHajV8mfRWnajZanB52m3lvdw5xvglVxn6g1ar5V07V4DcC5glktLodJ4JDG303Kefoa77Q/iLrlkFW4kttWt/wDpr+6lA/31GD+K/jWkMXF6SVjOeFkvh1PbKK4rSviVoN26x3rT6ZKeP9LUCM/9tFJUfiR9K7KGWOeJZIZEkjYZV0OQR7EV0xnGWzOeUXHdHnHxqh/caFdY+7cyQZ/34y3/ALTrxDxXHgqQPvAivoH4xQeZ4O8//n2u4JPzcJ/7PXhXiWMNFGx7GvPxStUO/DO8Da8EeGbvxpfJGnmQaTFh7q5H8RPJVSernPJ5xnJ7Z+iNK0600mwhstOt0t7WEbUjQYA/xJ6knkmsL4YeT/wr7Qfs8aRqLRAQgABYDDH6kgk+5rqK7KFJQjdbs5K1RzlbsFcx8Q9JfVPD7vbRl7q0bz41UZLgAhkHuVJwPULXT0VrKKkrMzjJxakuh8+WUqhwVYMjcqQeCK3LduhFHj3RBofiAvCpWyvi0sWBwj9XT/2YfUgfdqvpsnmKBXhzg6cnFnvxqKrBTRu2r5FZ+vRF0DDtVyAFakvIvNgIoeqJTs7nmfh9jBqeoWrcbJiwHseR/Ou3twHt+a43UEFl4vRjwtxDgf7ynn9CtdlpjhkxSe5p9kydUvItPtZ0uFwks0MsUgH3JVba2f8AejZlz/sj1re02b5Nnviua+IcRGhTOnVfmrd0ZxI55yM8VTd0jPlSu0bLRkjgZzWbY33/AAjvia11CQ7bV/3F0ewjY/eP+6wBz2G71roo4/u8daytds1lDqygjGCCK0V4NSXQy0mnB9T1McjiiuL+HGtiez/sW7Yi9skxGWOfNhBwrc9SvCn8D/FXaV60JKa5kePODhJxZ5v8Q4w3jPRsdTay/o6/41T1fWI9LkijkDMSedoJ4xknj0AJPoAa0fHxx4y0XI4+yzf+hpXPhP7Q8U38UgA8nTLuaM/7WwR/ykavPqx5qzS6/wCR6VF2opvp/mdH5sE1i8zbQu3dk9q4m5vRqGoaRbwtmWa6hXj085QG/Dr+FXLy7K+CJ5FOGMBwR9KofDyyFz4+06NVytnH5jj2WNh/6FKlYx9+cUbtKFOTPeaKKK9g8QKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK8x+NZ/wCQCP8AprMf/HP/AK9enV5d8bTiXw/u4UyTjJ9dq4H8/wAqxxH8Nm1D+IjhPhYvmfFOyY87Flb/AMhMP619GV89/CBAfiYPVLeVsenQf1r6EqML8BeK+MpT6XZTXHnyW6GXIYkcbiOhI6EjtnOKzbPw3FaxG2E5exONyMnzsB0QtnGz/ZCj3Jyc79FbuEXrYwUmuoUUUVRJzPiPwN4e8Q73v9PjW5b/AJeYP3cufdh1/HIrzrXPg5eWpMvhvUxMo/5YXnyt+DqMH/vkfWva6KynRhPdGkKs4bM+WtTg1nw/J5Wt2E9sM7d8i5Rvo4yp/OptE1qTT5/M0m9uNOlJyRA2EY+6HKn8RX05LEk0TRzIskbjDKwyCPQiuK1/4YeG9VUtb2p0y47SWWEX8Uxt/QH3rmlhWtYM6Y4pPSaPPfEHjrV77wtqNjqNvaXcUkWRPFmKRSpDAkchuR221ymvKHsGYc9xXU678MvEmlxyjT5ItWtGUgiP93KBj+4xwfwb8K5SRjLoETMMMYVJz2OK56vPf3zopclvcPbvgrP5/wAOtOUnLRPNGfwlYj9CK7mvMP2fJ/M8HXsROTDfOAPYojfzJr0+vSpO8EedVVpsKKKK0MzK8T6LBr+jzWM52McPFKBkxyD7rD+o7gkd68cslmtJ5IblQlxC5ilQHO1xwR9O4PcEGveK4D4k6IU/4ntnHkoAt6ij7yDpJ9V7/wCz/uiuTFUeePMt0dmDr+zlyPZmPbyBlFXY8MpFc/Y3PzYzW1BJjBrzUz0pRscL8RLNrcW19GObeYbj/stwf1xVzRr0FV55xXR69YpqNjNBIPkkQqT9RXnuiadrMds+LC7uBbyGFngjMuCO5C5KgjnJA4ocW9i4TjtJnUa/EL3S5o25BWofBs++wtSW3OF2Mf8AaX5T+oqhb6ruLxMwLLw655U+hHaqvhu7+w6zdWrnEcp8+LPr0YfyP51KfQpx0PWYJR9mBPamX7IyK/HzDmuesNUys0MrcH5kJotNTDQPbXBzIrHaT3Fa+0VrHP7Jp3G6rbTWU8Go6c227tm82JuxPdT/ALJGQfY16RZ+JNOuNEtNTaYRw3KblQ8vu6Mu0ckggg49K8zt74Ir2k5DAE7DnnBqLwhpyz61qdt9pMEfyzKAuSQ2chT25Gfq1bYatyvlXUyxNDmXM+hq+L9Tk1XxFo8tjYzMYhLEBkF2DbTkqOgGz1/i7VT1HT9R0iWbUpHhS5uoHs/Jxu2LIVycjuNvuOa7qwsbbT1Is4z5jfelfl2/H+lUfEmmm/sHQHEuMq2M4btWk1dufUypzslDocBNZ3N/bWvh/TAlxdyEfebaqopBYsQDgY4zjqQO9ej+BfB6+HGu7u5nW41G7x5jIuEjUdEXPP1PfA4FXfBuiWGk6aHsiZriYAz3MgHmOw7H+6Ac4UcD6kk9BW9CgoLme5jiMS6jcVogooorpOQKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKiuraC7gaG6hinhb70ciBlP1BqWigClp2k6dpm7+zdPtLTd977PCsefrgCrtFFFrAFFFFABRRRQAUUUUAFFFFABXzVq1sIJNRtcYEFxNCPosjKP5V9K189eLYTB4o8QwH+G7d+f8AbVZP/Z648YvdTOvCP3mjo/2d5sRa/a5+48MuP94OP/ZK9irwv4BT7PFGrW//AD1tA+P9x8f+z17pWuHd6aMsQrVGFFFFbmIU10WRGR1DIwwykZBHoadRQB4l4j0l/DOuGzXJspQZbRjz8meUPupIH0K981d02fzlGK6b4wwr/wAIvFdYHmW11GVPchjsI/8AHs/gK4bwpK0k9wh52EY/KvIxFNQqWXU9rD1HUo3e60OwhRZItjDnFZHmXfhzV11KwUSBgI7iEtgTR5zj2YckH3I6E1s2pHBp15CsybWGc0k2veW5Ls/dlszZtv8AhHfHGnieS0huTH8jLNGFmgb+6SOVPuDg9QSK4/xT8Kxxe+Hb2ZZ7c+YlrcfOGx1VX+8MjI+bd17VWfTrrT75b7SpntrpBjenIdf7rDoy+x/DB5rrvDfjWG7mjsdbRbHUWO1G/wCWM5/2GPQn+6efQt1rshUp1tJrU5Z06lD3qb0PHNSupEtYL+2YmND+9QjBx347EUuqzNH9i1KFz5QID4PVT/h1r1Hxb8O/7SvLi70a7js5Lklp4JULRux6sMHKk9+oJ54Oc8FqHhHXNGgk0mbT59RtyP3VxaxF1YHsQMlSOnP1riqYWcHoro9Cli6dRLWzKWvho2tNSgJPlkbwO6nr/j+FdD4cu44vFenSKcm5R4cD/d35/wDHKpw+DvEp0iOHUbWK3tyoWSV5QzKp45VSefUfrXX+GvBthpM0VwJJ7i4iBVXmfOOPQYGffHeiFKcZJvQmrXpuDSdzrlGTT5FDKRTV4qXqtdjR5yepn2M5sdSVWOILghGHYP2P49Py9K6SuZ1ODzYWHI46jqK3tOnNzYwSv990Bb69/wBa1oS+yZ1o/aLFFFFdBgFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFeG/EyDyfHWo8Y+0W8M/14ZP8A2nXuVeQfGWNYPE2l3DkKLm0eIEnGSjg4+v7w1z4pXpnRhnaoc38Fcw/EVsnAks5U+vzIcf8AjtfQdfOfw3mFt8TdKUn/AFjSoR7GJ/64r6MpYR+4PFL3wooorpOYKKKKAOF+MrFfBwA6Ndwg/nn+leY6LePYX5cqWimAyR2PvXsXxH0ifWvCF7bWa77pCk8Sd2KMG2j3IBA9zXhtheA4U5BU7SCMEEdQR2PtXl45NTUj2MvtKm4+Z6Xb3CuoZOAa0IpQ2MmuKsNR2gKTmt22u9wBFc8Zms6Z0exJVwQKzNT0aG6idJIlkRhggjINOt7sdzWhFcZHXIrb3ZbmHvQehh6bq2s+HX25l1PTgeYJXzLGP9hz1/3W/ArXbaJ4m0rWSsdpdKt0Rk2sw8uYY6/IeSPcZHvWBcxo6kjrWFqWlWl4R9ohVipypxyp9QexrWGIlT0eqM5UIVdVoz1ORFkjZHAZGBBB7iubaKTTrjyZSzQk/u5D3HofcfrXIWXiHV9GvFskvVvExuSHUM5YeiTDnPruDGtxvGVpeW8kGradd2qg7XnixNHE2AQcj5+Mg52Y9a3dSFVaPUw9jUpPa6NvzUHVhU0bqe4xWfp7+bbhlZSc4JU5U+49qtKDnlEPvWaZTQt0MrxWho3GnRj0LD/x41nyRng4AHfnNQWlzNZXLqvzRsdxQ/zHvRTmoSuxTi5xsjpKKgtLqK6QtE3I+8p4ZfqKnrtTvqjkatowooopiCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKgvbO2v7dre+t4bmBvvRzIHU/UHip6KAM3StC0nSGZtL0yys2bhmghVC31IHNaVFFJK2wN33CiiimAUUUUAFcz4i8EaJr07XN1bNDeEc3Ns3luf97s3/AAIGumopOKkrMqMnF3i7Hluo/C2dMtpGsZx0S7iyT9XTGP8AvmsG50nxRoeftmlyTwj/AJa2Z89fyHz/AJqK9wornlhKcttDphjasd3f1PC7LxBDKSCwDqcMO6n0I7Gtu21JSAUcYr0bWNA0rWBnU7C3uH27RIyYkUf7Lj5h+Brz/XPhveWpabw5emVBz9kumww9lk/ow+rVyzwk46xdzqp4unPSasWor8PwTTpZAVJHOOwrhZry+0aQLrNpc2J3bc3CFVJ9Fb7rfgTVu41cTW3m2N1suIxlUyCr+zD+o5rmba0kdPs09Y6k9+Furea5hb7XbKxaW2kGHjI6lDwVYenX0xWZC9zNNFBo8n2hb0CGGaWQKQW4wx7r74z25J5Gu31u7Q6PH5mpMDFNbR8+aQwHze2M/McY78V6N4M8Bx6bJFqOrO8l+X877OrDyYm7EADlu+c4yc+hrejSlN6bGVatGlHXcu6VYjRwulhy628USI7dWUIq5/MGtIGjxLA0bQ6hH/yy+SUf7BPB/A/oTTI3DoGU5BFb1I8sjjhLmjckLZHNQypuIYdRUhFC1G7K2IZoWCrPCzRzJyGX/PT2rZ0u7N7ZRzMoV+VcDsQcGqIGY2FL4fljX7RblgJPMLBT3GB/ga3ou0rGNVXjc2KKKK6jmCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAGyxpLG0cqK6MMMrDIP1FYUng3w1JL5j6Bpe7qcWyAH6jGDW/RSaT3Gm1sRW1vDbQJDbRRwwoAqpGoVVHoAOlS0UUxDZEWRGR1DIwIIPQiuXhiawu5LNiSq8xknqh6f4fhXVVieJI9rWlyByr+W30PP8x+tY1o3jc1oytK3cVBuFNxinWzDd6/Tmo7uQoW2qT+lcyWlzpvrYswDKtWRcQFb1mB25GQQcYNaWnu0g+YgewpLiJPNztBI7mnJXSZMXZkmkap5z/ZrogTj7rdBIP8f/ANY9teuWukjuX8mFGluOu2M8r7k/w/WujskmjtIkuXEkwUBmHc100pOS1MKsUndE1FFFamQUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFZXicgaPJnH+six/38WtWqupWMOo2rW9yGMZIPytg5BzUyV00VF2aZkRXtvAvzyLkDlV5I/AVVnvpJ8m2srmZD0ZVyPzGa27PRrC0x5UAJHQuS2PzrQrFUX1Zs6y6I5S2ttZmOEgS0jP8cjgtj6DOK04NDTO69uZ7g/3dxVPyz/WtiitFSijN1ZPyI4IIrePZBGkaf3UUAVJRRWhmFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAf/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 476px\">",
"   <div class=\"ttl\">",
"    Heel-pocket-out method to put on compression stockings",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 456px; height: 611px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The heel-pocket-out method to put on compression stockings is as follows:",
"    <br>",
"     <ol>",
"      <li>",
"       Turn the leg part of the stocking inside-out down to the heel (as shown in A).",
"      </li>",
"      <li>",
"       Put your foot into the stocking, hold onto the folded edge, and pull the stocking onto your foot and over the heel (as shown in B).",
"      </li>",
"      <li>",
"       Gently work the stocking up your leg by turning it right-side out (as shown in C).",
"      </li>",
"     </ol>",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Using a stocking donner to put on compression stockings",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 345px; height: 498px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_36_15944=[""].join("\n");
var outline_f15_36_15944=null;
var title_f15_36_15945="Treatment and prevention of sudden cardiac arrest in dialysis patients";
var content_f15_36_15945=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment and prevention of sudden cardiac arrest in dialysis patients",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/36/15945/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/36/15945/contributors\">",
"     Charles A Herzog, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/36/15945/contributors\">",
"     J Michael Mangrum, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/36/15945/contributors\">",
"     Rod Passman, MD, MSCE",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/36/15945/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/36/15945/contributors\">",
"     Jeffrey S Berns, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/36/15945/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/36/15945/contributors\">",
"     Alice M Sheridan, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?15/36/15945/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 13, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dialysis patients are at extraordinarily high risk for death. In 2008, the annual mortality rate for prevalent United States dialysis patients was 200",
"    <span class=\"nowrap\">",
"     deaths/1000",
"    </span>",
"    patient-years [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cardiac disease is the major cause of death, accounting for 39 percent of all-cause mortality in dialysis patients [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/1\">",
"     1",
"    </a>",
"    ]. In the United States Renal Data System (USRDS) database, the single largest specific cause of death is attributed to arrhythmic mechanisms or sudden cardiac arrest (SCA) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/13/37082?source=see_link\">",
"     \"Patient survival and maintenance dialysis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the past, the term sudden cardiac death (SCD) has been used even if a patient were successfully resuscitated. Such cases have been referred to as \"aborted SCD\" or \"resuscitated SCD,\" and patients who experienced such events were said to be \"sudden death survivors.\" Clearer and more rational definitions of SCA and SCD were proposed in 2006 by the American College of",
"    <span class=\"nowrap\">",
"     Cardiology/American",
"    </span>",
"    Heart",
"    <span class=\"nowrap\">",
"     Association/Heart",
"    </span>",
"    Rhythm Society",
"    <span class=\"nowrap\">",
"     (ACC/AHA/HRS)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    \"[Sudden] cardiac arrest is the sudden cessation of cardiac activity so that the victim becomes unresponsive, with no normal breathing and no signs of circulation. If corrective measures are not taken rapidly, this condition progresses to sudden death. Cardiac arrest should be used to signify an event as described above, that is reversed, usually by CPR",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    defibrillation or cardioversion, or cardiac pacing. Sudden cardiac death should not be used to describe events that are not fatal.\"",
"   </p>",
"   <p>",
"    Throughout this topic review, we will use the terms SCA and SCD as defined in the 2006",
"    <span class=\"nowrap\">",
"     ACC/AHA/HRS",
"    </span>",
"    document.",
"   </p>",
"   <p>",
"    The treatment of SCA and the prevention of SCD in the dialysis population are provided in this topic review. Detailed discussions of SCA in the patient without kidney disease and the epidemiology and evaluation of SCA in dialysis patients are presented separately in appropriate topic reviews. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/1/11288?source=see_link\">",
"     \"Evaluation of sudden cardiac arrest and sudden cardiac death in dialysis patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/55/890?source=see_link\">",
"     \"Overview of sudden cardiac arrest and sudden cardiac death\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of SCA consists of acute resuscitation, which is the same in patients with and without renal failure. With respect to those with ESRD, electrolyte issues are particularly important in this setting. Thus, the 2006 American College of Cardiology",
"    <span class=\"nowrap\">",
"     (ACC)/American",
"    </span>",
"    Heart Association",
"    <span class=\"nowrap\">",
"     (AHA)/European",
"    </span>",
"    Society of Cardiology (ESC) guidelines state the following: \"The acute management of ventricular arrhythmias in end-stage renal failure should immediately address hemodynamic status and electrolyte (potassium, magnesium, and calcium) imbalance [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/3\">",
"     3",
"    </a>",
"    ].\" (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/24/8585?source=see_link\">",
"     \"Supportive data for advanced cardiac life support in adults with sudden cardiac arrest\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     External defibrillators in the dialysis unit",
"    </span>",
"    &nbsp;&mdash;&nbsp;While the majority of SCA events in dialysis patients do not occur during the delivery of hemodialysis, those that do provide the opportunity for rapid and appropriate interventions that may improve survival. A specific issue in the hemodialysis population is whether external defibrillators should be present in all dialysis units to facilitate prompt defibrillation of ventricular",
"    <span class=\"nowrap\">",
"     fibrillation/ventricular",
"    </span>",
"    tachycardia.",
"   </p>",
"   <p>",
"    The rationale is that overall success depends in part on how quickly defibrillation is performed as well as the high rate of SCA in dialysis units. It is estimated, for example, that the SCA rate in dialysis units is 3.8 to 7 per 100,000 hemodialysis sessions [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/4-6\">",
"     4-6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are a few studies that provide detailed data on cardiac arrest and arrhythmia occurring during dialysis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One study of 47 sudden cardiac arrests occurring in dialysis centers in Seattle and King County (United States) found that the annual incidence was about 0.75 SCA events per center [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/7\">",
"       7",
"      </a>",
"      ]. In 29 patients (62 percent), the cardiac rhythm was ventricular fibrillation (VF) or ventricular tachycardia (VT), with an overall survival to hospital discharge of 30 percent for the whole group and 38 percent for the",
"      <span class=\"nowrap\">",
"       VT/VF",
"      </span>",
"      group [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another study reported the outcome of cardiopulmonary resuscitation (including SCA) in one Montreal, Canada dialysis center during the period from 1997 to 2004 that involved over 307,553 dialysis sessions [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/9\">",
"       9",
"      </a>",
"      ]. An arrhythmia was identified in 19 patients; VT or VF was documented in six (32 percent). A total of 24 sudden cardiac arrests were reported, with 18 patients (75 percent) surviving 30 days, and 14 patients (58 percent) surviving 60 days.",
"     </li>",
"     <li>",
"      A third retrospective study evaluated 102 sudden cardiac arrests occurring at a dialysis center [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/5\">",
"       5",
"      </a>",
"      ]. Among 72 cases, the initial abnormality was ventricular fibrillation or tachycardia. Survival was only 15 percent at one year among those who survived transportation to the hospital.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Given the frequency of sudden cardiac arrests in dialysis units, these data would suggest that onsite defibrillation capability in all dialysis centers would be beneficial. A large amount of published data suggests that healthcare workers can use automated external defibrillators (AEDs) safely and effectively. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/39/25208?source=see_link\">",
"     \"Automated external defibrillators\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, limited data suggest that AEDs in dialysis centers may not provide a significant survival benefit [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/6\">",
"     6",
"    </a>",
"    ]. In one study, there was no significant difference in one year survival after SCA in centers with and without AEDs (8.8 and 7.5 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/6\">",
"     6",
"    </a>",
"    ]. One key question from this study is how cardiac arrest survivors from dialysis units were subsequently managed. The long-term benefit of successful onsite defibrillation may be attenuated by recurrent future cardiac events if the surviving patients received no further interventions, such as the treatment of myocardial ischemia or defibrillator implantation.",
"   </p>",
"   <p>",
"    Even when an AED is available, the device may not be appropriately used. In one study, for example, an AED was found to be attached prior to the arrival of emergency personnel in only 50 percent of dialysis patients with SCA who were being treated in centers with AEDs [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/5\">",
"     5",
"    </a>",
"    ]. The reasons for the underutilization of this device are unclear.",
"   </p>",
"   <p>",
"    Despite these limited data, we agree with the 2005 National Kidney Foundation Dialysis Outcome Quality Initiative",
"    <span class=\"nowrap\">",
"     (K/DOQI)",
"    </span>",
"    Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients, which recommends basic life support (CPR) training for dialysis unit staff and onsite capability for external cardiac defibrillation either with an AED or standard manual defibrillator [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A paucity of evidence exists concerning the prevention of SCA in dialysis patients. This is principally because of the exclusion of dialysis patients from nearly all clinical trials that used SCA or SCD as an endpoint and the absence of any subgroup analyses on those occasions when this population was included.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     General measures unique to dialysis patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optimal approach to general measures for primary and secondary prevention of SCA in the dialysis patient is unclear. It may vary in part with the dialysis patient's risk of SCA. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/1/11288?source=see_link&amp;anchor=H4#H4\">",
"     \"Evaluation of sudden cardiac arrest and sudden cardiac death in dialysis patients\", section on 'Risk factors and causes'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Avoiding low potassium dialysate",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although dialysis patients are generally at increased risk of SCA, cardiac arrest during hemodialysis remains a particular concern. An increased risk of cardiac arrest may be associated with a low potassium concentration in the dialysate. In a retrospective study of dialysis unit-based cardiac arrest, patients who suffered a cardiac arrest at the time of dialysis were twice as likely to be dialyzed against a zero or 1.0",
"    <span class=\"nowrap\">",
"     mEq/L",
"    </span>",
"    potassium dialysate bath compared to controls, despite the same predialysis potassium levels [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/4\">",
"     4",
"    </a>",
"    ]. Another study found an independent twofold increase in sudden death for patients dialyzed with a potassium bath of less than 2.0",
"    <span class=\"nowrap\">",
"     mEq/L",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/11\">",
"     11",
"    </a>",
"    ]. In this study there was no evidence for a benefit of low potassium dialysate even among patients with higher predialysis serum potassium levels. In another study of 37,765 participants, compared with dialysate potassium &ge;3",
"    <span class=\"nowrap\">",
"     mEq/L,",
"    </span>",
"    dialysate concentrations &le;1.5 and &le;2.0-2.5",
"    <span class=\"nowrap\">",
"     mEq/L",
"    </span>",
"    were associated with increased risk of sudden cardiac death (SCD) (HR of 1.39, [95% CI 1.12-1.74] and HR 1.17 [95% CI 1.01-1.37], respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/12\">",
"     12",
"    </a>",
"    ]. The magnitude of the association of SCD with dialysis potassium &le;1.5 was greater among patients with serum potassium &lt;5",
"    <span class=\"nowrap\">",
"     mEq/L.",
"    </span>",
"   </p>",
"   <p>",
"    Given",
"    this increased hazard of cardiac arrest, it is prudent to avoid the use of low potassium dialysate baths when feasible (&lt;2.0",
"    <span class=\"nowrap\">",
"     mEq/L",
"    </span>",
"    potassium). However, the nephrologist is presented with a very difficult problem in medically noncompliant patients who routinely have chronic hyperkalemia. In such patients, scheduling more frequent dialysis sessions is preferred, if possible, to the use of very low potassium dialysate baths, particularly in light of the study cited above [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/11\">",
"     11",
"    </a>",
"    ]. This approach reduces the magnitude of acute intra-dialytic potassium changes and permits the use of higher potassium baths, thereby avoiding postsession hypokalemia. However, if more frequent dialysis sessions are not feasible, the nephrologist may not have the luxury of an \"ideal\" dialytic prescription regarding potassium baths.",
"   </p>",
"   <p>",
"    Any dialytic therapy that is associated with significant hypokalemia is associated with an increased hazard of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/27/29113?source=see_link\">",
"     digoxin",
"    </a>",
"    -related tachyarrhythmias. In patients who are known to have large, unavoidable fluctuations in serum potassium levels, we would therefore recommend avoidance of digoxin, if possible.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Nocturnal hemodialysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although unproven, long duration quotidian dialysis might reduce the risk of SCA in hemodialysis patients since it minimizes the large volume and electrolyte shifts that occur with conventional thrice weekly dialysis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/16/264?source=see_link\">",
"     \"Technical aspects of nocturnal hemodialysis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Use of specific medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Issues surrounding the use of specific medications in dialysis patients with heart failure",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    an increased risk of SCA are discussed below and in appropriate topic reviews. Some of these medications include beta blockers, angiotensin converting enzyme inhibitors,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    angiotensin II receptor blockers. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Heart failure'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/61/26584?source=see_link\">",
"     \"Myocardial dysfunction in end-stage renal disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following is a review of some of the data concerning the use and effect on SCA of medications including beta blockers, angiotensin converting enzyme inhibitors,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    angiotensin II receptor blockers in dialysis patients. There are currently NO compelling data to support the use of medications for prevention of SCA in dialysis patients without LV dysfunction.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      It is unclear whether beta-adrenergic blockers reduce the risk of SCA and SCD in dialysis patients without heart failure. One observational report from the US Subset of the Dialysis Outcomes and Practice Patterns Study (DOPPS) found that beta-adrenergic blockers are underutilized, with only 24 percent of dialysis patients with coronary artery disease or prior myocardial infarction receiving the therapy. However, hemodialysis patients treated with beta-adrenergic blockers had lower overall mortality, although cause-specific mortality was not reported [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/13\">",
"       13",
"      </a>",
"      ]. In a subsequent analysis of DOPPS, beta blockers were associated with a lower risk of SCD among dialysis patients (hazard ratio of 0.88, 95% CI 0.78-0.99) [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Retrospective studies have suggested a survival benefit from the use of ACE inhibitors in dialysis patients [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/14,15\">",
"       14,15",
"      </a>",
"      ]. As an example, one retrospective study of 60 hypertensive dialysis patients treated with ACE inhibitors and 60 patients not treated with such agents found a 52 percent risk reduction in all-cause mortality despite no significant difference in blood pressure reduction (RR 0.48; 95% CI 0.25-0.91) [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/14\">",
"       14",
"      </a>",
"      ]. Whether the favorable effects reported in these studies derived from a reduction in SCD is unknown. In contrast to these studies, one randomized placebo controlled trial of the ACE inhibitor",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/30/16872?source=see_link\">",
"       fosinopril",
"      </a>",
"      in dialysis patients with left ventricular hypertrophy failed to show any benefit of active treatment in the occurrence of cardiovascular events including cardiac arrest [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/16\">",
"       16",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/46/20202?source=see_link\">",
"       \"Hypertension in dialysis patients\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Angiotensin II receptor blockers may provide protection against cardiovascular mortality, including SCD, among general dialysis patients. In one trial, 80 dialysis patients with no clinical evidence of cardiovascular disease were randomly assigned to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/48/38663?source=see_link\">",
"       candesartan",
"      </a>",
"      4 to 8",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      or no therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/17\">",
"       17",
"      </a>",
"      ]. There was a significant reduction in cardiovascular events and total mortality in the treatment group (zero and four sudden",
"      <span class=\"nowrap\">",
"       deaths/severe",
"      </span>",
"      arrhythmias in the treatment and standard therapy arms, respectively). Serum potassium levels were not significantly affected by active treatment [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/17\">",
"       17",
"      </a>",
"      ]. However, further studies are necessary before the use of angiotensin receptor blockers in dialysis patients without heart failure can be recommended.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     SECONDARY PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The immediate treatment of SCA consists of acute resuscitation. This is followed, in survivors, by attempted long-term prevention of recurrence by nonpharmacologic and less often pharmacologic therapies.",
"   </p>",
"   <p>",
"    The type of medication being administered at the time of the event may impact upon survival post-SCA. This was shown in a retrospective study of 729 patients who sustained a cardiac arrest in a hemodialysis clinic, of whom 310 and 80 patients survived 24 hours and 6 months, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/18\">",
"     18",
"    </a>",
"    ]. After statistical adjustment, beta blocker therapy was significantly associated with survival at 24 hours (odds ratio 0.61, 95% CI 0.44-0.86), while survival at six months was associated with beta blockers (OR of 0.32, CI 0.17-0.61), ACE",
"    <span class=\"nowrap\">",
"     inhibitors/ARBs",
"    </span>",
"    (OR of 0.51, CI 0.28-0.95), and calcium channel blockers (OR of 0.42, CI of 0.23-0.76).",
"   </p>",
"   <p>",
"    Although intriguing, the interpretation of this study is difficult since the use of an automated external defibrillator was not clearly incorporated in the analysis and the treatment of survivors was not adequately explained [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/19\">",
"     19",
"    </a>",
"    ]. In addition, this study was limited by confounding by indication. This issue requires further study in large prospective randomized trials.",
"   </p>",
"   <p>",
"    General issues surrounding secondary prevention are similar in patients with and without end-stage renal failure. This is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/24/8585?source=see_link\">",
"     \"Supportive data for advanced cardiac life support in adults with sudden cardiac arrest\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/24/4490?source=see_link\">",
"     \"Evaluation of the survivor of sudden cardiac arrest\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Implantable cardiac defibrillator",
"    </span>",
"    &nbsp;&mdash;&nbsp;For nondialysis patients who have survived SCA or who have already manifested potentially life-threatening ventricular arrhythmias, well designed large prospective randomized studies have shown that placement of an implantable cardiac defibrillator (ICD) is superior to antiarrhythmic therapy in improving survival. As a result, resuscitated cardiac arrest is a class I indication for placement of an ICD. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/23/43385?source=see_link\">",
"     \"Role of implantable cardioverter-defibrillators for the secondary prevention of sudden cardiac death\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although there are no randomized prospective studies that have examined the outcomes after ICD placement in dialysis patients who have survived SCA, limited retrospective evidence suggests that ICDs lower mortality in such dialysis patients.",
"   </p>",
"   <p>",
"    We therefore recommend the use of ICDs for secondary prevention in dialysis patients. This is consistent with the 2006 American College of Cardiology",
"    <span class=\"nowrap\">",
"     (ACC)/American",
"    </span>",
"    Heart Association",
"    <span class=\"nowrap\">",
"     (AHA)/European",
"    </span>",
"    Society of Cardiology (ESC) guidelines which state [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      \"Life-threatening ventricular arrhythmias, especially in patients awaiting renal transplantation, should be treated conventionally, including the use of ICD and pacemaker as required, in patients who are receiving chronic optimal medical therapy and who have reasonable expectation of survival with a good functional status for more than one year\"",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The benefits of an ICD for secondary prevention in this setting were best described in a retrospective cohort study that evaluated the outcomes of dialysis patients who survived ventricular",
"    <span class=\"nowrap\">",
"     fibrillation/cardiac",
"    </span>",
"    arrest and either received an ICD (460 patients) or did not receive an ICD (5582 patients) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/20\">",
"     20",
"    </a>",
"    ]. ICD placement was associated with a significant reduction in risk of death (relative risk 0.58, 95% CI 0.50-0.66, (",
"    <a class=\"graphic graphic_figure graphicRef72475 \" href=\"UTD.htm?6/40/6799\">",
"     figure 1",
"    </a>",
"    )). Estimated survival at one, two, three, four and five years for those with and without ICD was 71 and 49 percent, 53 and 33 percent, 36 and 23 percent, 25 and 16 percent, and 22 and 12 percent, respectively. A retrospective study suggested a more modest estimate of the survival benefit associated with ICDs among dialysis patients [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/21\">",
"     21",
"    </a>",
"    ]. (",
"    <a class=\"graphic graphic_figure graphicRef54540 \" href=\"UTD.htm?6/42/6830\">",
"     figure 2",
"    </a>",
"    )",
"   </p>",
"   <p>",
"    Although the cited study may be limited by the retrospective nature of the study design and by possible confounding by indication, these data support the use of ICDs in the secondary prevention of SCD in dialysis patients.",
"   </p>",
"   <p>",
"    Despite this possible survival benefit, ICDs are markedly underutilized in dialysis patients. As an example, the previously described study found that only 8 percent of dialysis patients with a history of resuscitated cardiac arrest received such a device [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The USRDS Cardiovascular Special Studies Center has also published data on ICD utilization, temporal trends, and estimated survival in dialysis patients (",
"    <a class=\"graphic graphic_figure graphicRef69902 \" href=\"UTD.htm?32/22/33134\">",
"     figure 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef60670 \" href=\"UTD.htm?29/43/30398\">",
"     figure 4",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/1\">",
"     1",
"    </a>",
"    ]. In the time period 1999 to 2008, 9573 US hemodialysis patients received an ICD or cardiac resynchronization therapy with defibrillator (CRT-D) device (5541 for secondary prevention and 4032 for primary prevention of SCD). The estimated one-year mortality overall was about 40 percent. (",
"    <a class=\"graphic graphic_figure graphicRef73475 \" href=\"UTD.htm?11/44/11983\">",
"     figure 5",
"    </a>",
"    ). There was a progressive increase in utilization of ICDs for primary prevention of SCD over time. (",
"    <a class=\"graphic graphic_figure graphicRef75637 \" href=\"UTD.htm?11/24/11662\">",
"     figure 6",
"    </a>",
"    )",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     SCA during hemodialysis session",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among nondialysis patients, it has been thought that patients with a life-threatening ventricular tachyarrhythmia in the setting of a reversible arrhythmogenic disorder, such as ischemia or an electrolyte abnormality, have a low risk for recurrent SCA after correction of the underlying problem. Thus, CMS guidelines state that ICD placement is not recommended for arrhythmia due to reversible causes. Similarly, earlier ICD guidelines from national organizations stated that \"transient or reversible disorders\" were a contraindication to device implantation. However, the 2006 ICD guidelines cautioned against attributing an arrest to reversible causes [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/3\">",
"     3",
"    </a>",
"    ]. Most such patients, with or without ESRD, remain at high risk for SCD, even if coronary revascularization is performed and abnormalities are reversed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/21/30041?source=see_link\">",
"     \"Outcome of sudden cardiac arrest\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, the CMS guidelines were clearly not designed for dialysis patients (although they are CMS beneficiaries) since their application to the setting of SCA occurring during dialysis is problematic. It is unclear, for example, how to accurately define a preventable reversible cause among patients undergoing mandatory electrolyte shifts during a hemodialysis session. Although a simplistic approach would be to \"avoid large electrolyte shifts\", this cannot be accomplished with conventional thrice weekly hemodialysis sessions. Even patients being dialyzed with a 3.0 mEq potassium dialysate bath will be exposed to rapid intradialytic potassium shifts.",
"   </p>",
"   <p>",
"    The likelihood that a dialysis patient will be exposed to repeated electrolyte imbalances strongly suggests that these recommendations do NOT apply to this patient population. Thus, we recommend that dialysis patients resuscitated from SCA occurring during dialysis should be treated in exactly the same fashion as SCA occurring outside the hemodialysis center.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Issues in ICD placement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dialysis patients present unique challenges to ICD placement:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There is an increase risk of bleeding and infection following cardiac rhythm management device implantation in dialysis patients [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/22,23\">",
"       22,23",
"      </a>",
"      ]. In one study of 1400 dialysis patients receiving ICDs from 1996 to 2001, the estimated rate of device-related infections was 5.4 percent at two years after device implantation [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/23\">",
"       23",
"      </a>",
"      ]. In a retrospective study of 9528 patients who received an ICD between 1994 and 2006, the incidence rate for device infection was 42 events per 1000 patient-years [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/21\">",
"       21",
"      </a>",
"      ]. This rate stands in contrast to the very low incidence of device-related infections observed in the nondialysis cohort as exemplified by one study of 3344 ICD implants that observed only nine infections (0.27 percent) at one year of follow-up [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      There is a higher than expected prevalence of increased defibrillation thresholds in dialysis patients [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Device placement on the ipsilateral side as dialyses access has been associated with high rates of subclavian venous stenosis and occlusion [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    We therefore recommend careful hemostasis, avoidance of anticoagulation in the immediate perioperative period, placement of intravascular leads on the contralateral side of dialysis access, and use of high-output devices with left-sided prepectoral generator placement if possible.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     PRIMARY PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the general population, efforts to decrease the impact of SCD have focused specifically upon general measures (such as management of high blood pressure and hypercholesterolemia and reversing ischemia), patients with heart failure, and patients surviving an acute myocardial infarction (MI). It is unclear whether dialysis patients with similar clinical characteristics receive the same benefit in terms of primary prevention of SCD. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/55/890?source=see_link\">",
"     \"Overview of sudden cardiac arrest and sudden cardiac death\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following section will review the issues concerning possible interventions among dialysis patients with heart failure or heart failure post-MI. These last two groups have been identified in the general population as being at an increased risk of SCD and may benefit from an ICD",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    other interventions for primary prevention.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Heart failure",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Medical therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The medical management of heart failure in the hemodialysis patient is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/12/9416?source=see_link\">",
"     \"Therapy of heart failure in hemodialysis patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Implantable defibrillators",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are a wealth of clinical data supporting the use of implantable defibrillators (ICDs) for the primary prevention of SCD in high-risk nondialysis patients with cardiomyopathy. However, there are no prospective data on dialysis patients with cardiomyopathy. Patients were excluded from ICD trials if they were on dialysis or had no renal function data reported. In addition, dialysis patients, if included, have not been the subject of any subgroup analyses. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/12/19657?source=see_link\">",
"     \"Implantable cardioverter-defibrillators: Clinical trials of primary prevention of sudden cardiac death\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is also unknown whether the primary prevention benefits of an ICD for the nondialysis patient with a low left ventricular ejection fraction are also observed in the dialysis patient with LV dysfunction. Although it is tempting to conclude that any high-risk population will benefit from ICD therapy, it is plausible that competing risks in the dialysis cohort may reduce the favorable impact of device implantation on survival. Only retrospective and observational studies have evaluated this question. As examples [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/26-32\">",
"     26-32",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A 2009 meta-analysis of seven observational studies involving 2516 patients and 89 dialysis patients found that ICD patients on dialysis experienced a 2.7-fold greater risk of death compared with those not on dialysis [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/30\">",
"       30",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In one study of 585 ICD recipients, 19 (3.2 percent) were on dialysis prior to the implant, with 11 having a cardiomyopathy [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/26\">",
"       26",
"      </a>",
"      ]. Approximately one-half of the dialysis patients underwent implantation for primary prevention. The median survival time was significantly shorter among all ESRD patients versus those without ESRD (3.2 versus 7.4 years, respectively) [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/26\">",
"       26",
"      </a>",
"      ]. Among dialysis patients, the majority of deaths were due to non-device-related infection.",
"     </li>",
"     <li>",
"      According to data published by the USRDS Cardiovascular Special Studies Center, among 9573 US hemodialysis patients who received an ICD or cardiac resynchronization therapy with defibrillator (CRT-D) device between 1999 and 2008, the estimated one-year mortality overall was about 40 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/1\">",
"       1",
"      </a>",
"      ]. (",
"      <a class=\"graphic graphic_figure graphicRef73475 \" href=\"UTD.htm?11/44/11983\">",
"       figure 5",
"      </a>",
"      ). Similarly, in a retrospective cohort study that examined outcomes of 9528 patients who received an ICD between 1994 and 2006, mortality rates after implantation were 448 deaths per 1000 patients-years [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/21\">",
"       21",
"      </a>",
"      ]. (",
"      <a class=\"graphic graphic_figure graphicRef54540 \" href=\"UTD.htm?6/42/6830\">",
"       figure 2",
"      </a>",
"      ).",
"      <br/>",
"      <br/>",
"      This is much lower than that observed among nondialysis patients who receive an ICD for primary prevention, which is approximately 90, 85, and 80 percent at one, two, and three years, respectively. However, the survival of dialysis patients with similar clinical characteristics who did not receive an ICD is unclear.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, the presence of comorbidities in dialysis patients who meet current implant indications may reduce the survival benefit of ICDs for primary prevention in this population. However, none of these retrospective studies can adequately address whether ICDs prolong life in dialysis patients when used for primary prevention. A proposed clinical trial on the use of ICDs in this population would better define this issue.",
"   </p>",
"   <p>",
"    Despite the absence of clinical data supporting the use of ICDs in dialysis patients for the primary prevention of SCD, current implant guidelines do not exclude these patients [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/33\">",
"     33",
"    </a>",
"    ]. They also state that survival from noncardiac diseases must be expected to exceed one year [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We agree with current implant guidelines, which we also apply to patients with ESRD. Criteria are based in part upon the presence and severity of symptoms due to heart failure (as indicated by New York Heart Association (NYHA) class) and the degree of myocardial dysfunction as determined by the ejection fraction. Current implant indications are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/47/21241?source=see_link&amp;anchor=H21#H21\">",
"     \"Ventricular arrhythmias in heart failure and cardiomyopathy\", section on 'Prevention of SCD'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, there are difficulties in assessing NYHA class in some dialysis patients. This may make the application of existing guidelines particularly challenging. This further emphasizes the need for specifically designed trials within the dialysis population.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2408037328\">",
"    <span class=\"h3\">",
"     Wearable cardioverter-defibrillator",
"    </span>",
"    &nbsp;&mdash;&nbsp;A wearable external defibrillator may help to prevent SCD in dialysis patients who are awaiting placement of an ICD. The indications for this device are the same among dialysis patients as in the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/34\">",
"     34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/15/36088?source=see_link&amp;anchor=H6129259#H6129259\">",
"     \"Wearable cardioverter-defibrillator\", section on 'Indications for WCD use'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Post-myocardial infarction",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the general population, there are two components to the primary prevention of arrhythmic death after an acute myocardial infarction (MI): usual medical therapy for post-MI patients; and, in selected patients, implantation of an ICD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Medical therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;With respect to medical therapy in post-MI nondialysis patients, both beta blockers and ACE inhibitors (or angiotensin II receptor blockers) lower the incidence of SCD, reduce overall mortality, and are routinely administered. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/62/15338?source=see_link&amp;anchor=H2#H2\">",
"     \"Role of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death after myocardial infarction\", section on 'Medical therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The effect of medical therapy on prevention of SCD in dialysis patients with a history of myocardial infarction is unclear. There are no prospective controlled data specifically examining the effect of standard agents on SCD in dialysis patients with a history of myocardial infarction. A retrospective analysis of older chronic hemodialysis patients with an acute myocardial infarction found that ACE inhibitor therapy was associated with a significant 30-day mortality reduction (17 versus 33 percent), even after adjusting for clinical risk factors (RR 0.58; 95% CI 0.42-0.77) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/15\">",
"     15",
"    </a>",
"    ]. Whether the favorable effects reported in this study derived from a reduction in sudden cardiac death is unknown.",
"   </p>",
"   <p>",
"    Despite the absence of data in dialysis patients, we administer usual medical therapy, if appropriately dosed and not contraindicated, for the primary prevention of SCD after myocardial infarction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/62/15338?source=see_link&amp;anchor=H2#H2\">",
"     \"Role of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death after myocardial infarction\", section on 'Medical therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Implantable cardiac defibrillator",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among patients without renal disease, the ICD is currently the optimal method for preventing SCD in selected high-risk post-myocardial infarction patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/62/15338?source=see_link\">",
"     \"Role of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death after myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    By comparison, the role of an ICD in dialysis patients with heart failure post-MI is unclear, and dialysis patients were not included in any of the trials. Although extrapolation of results to the dialysis population may not be valid, there is no reason to think that benefits with ICD should not extend to dialysis patients.",
"   </p>",
"   <p>",
"    Thus, we recommend that current ICD guidelines for post-MI patients with heart failure also be used for similar dialysis patients who meet other implant indications. It is important to realize that these guidelines also state that survival from noncardiac diseases must be expected to exceed one year. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/62/15338?source=see_link\">",
"     \"Role of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death after myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2408037361\">",
"    <span class=\"h3\">",
"     Wearable cardioverter-defibrillator",
"    </span>",
"    &nbsp;&mdash;&nbsp;A wearable external defibrillator may help to prevent SCD in dialysis patients who are awaiting placement of an ICD. The indications for this device are the same among dialysis patients as in the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15945/abstract/34\">",
"     34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/15/36088?source=see_link&amp;anchor=H6129259#H6129259\">",
"     \"Wearable cardioverter-defibrillator\", section on 'Indications for WCD use'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The treatment of SCA consists of acute resuscitation, which is the same in patients with and without renal failure. We recommend basic life support (CPR) training for dialysis unit staff and onsite capability for external cardiac defibrillation (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Treatment'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/24/8585?source=see_link\">",
"       \"Supportive data for advanced cardiac life support in adults with sudden cardiac arrest\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The optimal approach to the implementation of general measures for primary and secondary prevention of SCA and SCD in the dialysis patient is unclear. It may vary in part with the dialysis patient's risk of SCA. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'General measures unique to dialysis patients'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Specific management issues surrounding secondary prevention are similar in patients with and without end-stage renal failure. Despite the absence of prospective controlled trials, we recommend the use of implantable cardioverter-defibrillators (ICDs) for secondary prevention in dialysis patients (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). We also manage dialysis patients resuscitated from SCA occurring during dialysis in exactly the same fashion as SCA occurring outside the hemodialysis center. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/23/43385?source=see_link\">",
"       \"Role of implantable cardioverter-defibrillators for the secondary prevention of sudden cardiac death\"",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H9\">",
"       'Secondary prevention'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In the nondialysis patient, significant evidence exists that some patients with heart failure or history of acute myocardial infarction who are at increased risk of SCD have marked survival benefits with an ICD placed for primary prevention. However, the presence of comorbidities and competing risks may reduce the favorable impact of ICD on survival among similar dialysis patients. Despite this possibility and the absence of data showing substantial survival benefit in the dialysis cohort, we feel that dialysis patients at increased risk for SCD will similarly benefit from ICD placement.",
"     </li>",
"     <li>",
"      We recommend the use of ICDs in dialysis patients with heart failure who meet implant indications as noted in current ICD guidelines for patients with a low ejection fraction and symptoms due to heart failure, independent of etiology (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). These guidelines also state that survival from noncardiac diseases must be expected to exceed one year. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/47/21241?source=see_link&amp;anchor=H21#H21\">",
"       \"Ventricular arrhythmias in heart failure and cardiomyopathy\", section on 'Prevention of SCD'",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H16\">",
"       'Implantable defibrillators'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Among dialysis patients with heart failure due to systolic dysfunction (defined as a left ventricular ejection fraction less than 35 percent), we recommend the use of beta blocker therapy for initial medical therapy (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). We suggest the use of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/22/9577?source=see_link\">",
"       carvedilol",
"      </a>",
"      as the preferred beta blocker (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Such therapy should be initiated at very low doses to minimize the risk of hemodynamic deterioration. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/38/12905?source=see_link&amp;anchor=H8#H8\">",
"       \"Use of beta blockers in heart failure due to systolic dysfunction\", section on 'Initiation of therapy'",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H14\">",
"       'Heart failure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In dialysis patients with heart failure who tolerate the beta blocker, we suggest initiation of ACE inhibitor therapy (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Our approach to initiation is described above. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Heart failure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend the use of ICDs in post-MI dialysis patients with reduced left ventricular ejection fraction who meet implant indications as noted in current ICD guidelines for patients with a prior infarction and a low ejection fraction, independent of symptoms (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). It is important to realize that these guidelines also state that survival from noncardiac diseases must be expected to exceed one year. Despite the absence of data in dialysis patients, we also administer usual medical therapy, if appropriately dosed, for the primary prevention of SCD after myocardial infarction. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/62/15338?source=see_link&amp;anchor=H2#H2\">",
"       \"Role of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death after myocardial infarction\", section on 'Medical therapy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      If an ICD is placed (for either secondary or primary prevention), we recommend careful hemostasis, avoidance of anticoagulation in the immediate perioperative period, placement of intravascular leads on the contralateral side of dialysis access, and use of high-output devices with left-sided prepectoral generator placement, if possible. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Issues in ICD placement'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     US Renal Data System: USRDS 2011 Annual Data Report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2011.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15945/abstract/2\">",
"      American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Develop Data Standards on Electrophysiology), Buxton AE, Calkins H, et al. ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Develop Data Standards on Electrophysiology). Circulation 2006; 114:2534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15945/abstract/3\">",
"      European Heart Rhythm Association, Heart Rhythm Society, Zipes DP, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006; 48:e247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15945/abstract/4\">",
"      Karnik JA, Young BS, Lew NL, et al. Cardiac arrest and sudden death in dialysis units. Kidney Int 2001; 60:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15945/abstract/5\">",
"      Davis TR, Young BA, Eisenberg MS, et al. Outcome of cardiac arrests attended by emergency medical services staff at community outpatient dialysis centers. Kidney Int 2008; 73:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15945/abstract/6\">",
"      Lehrich RW, Pun PH, Tanenbaum ND, et al. Automated external defibrillators and survival from cardiac arrest in the outpatient hemodialysis clinic. J Am Soc Nephrol 2007; 18:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15945/abstract/7\">",
"      Becker L, Eisenberg M, Fahrenbruch C, Cobb L. Cardiac arrest in medical and dental practices: implications for automated external defibrillators. Arch Intern Med 2001; 161:1509.",
"     </a>",
"    </li>",
"    <li>",
"     Linda Becker, personal communication.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15945/abstract/9\">",
"      Lafrance JP, Nolin L, Sen&eacute;cal L, Leblanc M. Predictors and outcome of cardiopulmonary resuscitation (CPR) calls in a large haemodialysis unit over a seven-year period. Nephrol Dial Transplant 2006; 21:1006.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15945/abstract/10\">",
"      K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005; 45:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15945/abstract/11\">",
"      Pun PH, Lehrich RW, Honeycutt EF, et al. Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics. Kidney Int 2011; 79:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15945/abstract/12\">",
"      Jadoul M, Thumma J, Fuller DS, et al. Modifiable practices associated with sudden death among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Clin J Am Soc Nephrol 2012; 7:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15945/abstract/13\">",
"      Ritz E, Dikow R, Adamzcak M, Zeier M. Congestive heart failure due to systolic dysfunction: the Cinderella of cardiovascular management in dialysis patients. Semin Dial 2002; 15:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15945/abstract/14\">",
"      Efrati S, Zaidenstein R, Dishy V, et al. ACE inhibitors and survival of hemodialysis patients. Am J Kidney Dis 2002; 40:1023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15945/abstract/15\">",
"      Berger AK, Duval S, Krumholz HM. Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. J Am Coll Cardiol 2003; 42:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15945/abstract/16\">",
"      Zannad F, Kessler M, Lehert P, et al. Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies. Kidney Int 2006; 70:1318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15945/abstract/17\">",
"      Takahashi A, Takase H, Toriyama T, et al. Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis--a randomized study. Nephrol Dial Transplant 2006; 21:2507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15945/abstract/18\">",
"      Pun PH, Lehrich RW, Smith SR, Middleton JP. Predictors of survival after cardiac arrest in outpatient hemodialysis clinics. Clin J Am Soc Nephrol 2007; 2:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15945/abstract/19\">",
"      Herzog CA. Can we prevent sudden cardiac death in dialysis patients? Clin J Am Soc Nephrol 2007; 2:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15945/abstract/20\">",
"      Herzog CA, Li S, Weinhandl ED, et al. Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int 2005; 68:818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15945/abstract/21\">",
"      Charytan DM, Patrick AR, Liu J, et al. Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Am J Kidney Dis 2011; 58:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15945/abstract/22\">",
"      Dasgupta A, Montalvo J, Medendorp S, et al. Increased complication rates of cardiac rhythm management devices in ESRD patients. Am J Kidney Dis 2007; 49:656.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15945/abstract/23\">",
"      Herzog, CA. LSCA: Risk and Outcome of Infected Pacemakers and Defibrillators in Dialysis Patients [Abstract]. Circulation Suppl 2004; 110:III.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15945/abstract/24\">",
"      Gradaus R, Block M, Brachmann J, et al. Mortality, morbidity, and complications in 3344 patients with implantable cardioverter defibrillators: results fron the German ICD Registry EURID. Pacing Clin Electrophysiol 2003; 26:1511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15945/abstract/25\">",
"      Teruya TH, Abou-Zamzam AM Jr, Limm W, et al. Symptomatic subclavian vein stenosis and occlusion in hemodialysis patients with transvenous pacemakers. Ann Vasc Surg 2003; 17:526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15945/abstract/26\">",
"      Robin J, Weinberg K, Tiongson J, et al. Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients. Heart Rhythm 2006; 3:1196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15945/abstract/27\">",
"      Eckart RE, Gula LJ, Reynolds MR, et al. Mortality following defibrillator implantation in patients with renal insufficiency. J Cardiovasc Electrophysiol 2006; 17:940.",
"     </a>",
"    </li>",
"    <li>",
"     US Renal Data System: USRDS 2006 Annual Data Report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2006.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15945/abstract/29\">",
"      Hreybe H, Razak E, Saba S. Effect of end-stage renal failure and hemodialysis on mortality rates in implantable cardioverter-defibrillator recipients. Pacing Clin Electrophysiol 2007; 30:1091.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15945/abstract/30\">",
"      Sakhuja R, Keebler M, Lai TS, et al. Meta-analysis of mortality in dialysis patients with an implantable cardioverter defibrillator. Am J Cardiol 2009; 103:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15945/abstract/31\">",
"      Amin MS, Fox AD, Kalahasty G, et al. Benefit of primary prevention implantable cardioverter-defibrillators in the setting of chronic kidney disease: a decision model analysis. J Cardiovasc Electrophysiol 2008; 19:1275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15945/abstract/32\">",
"      Aggarwal A, Wang Y, Rumsfeld JS, et al. Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation. Heart Rhythm 2009; 6:1565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15945/abstract/33\">",
"      Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J 2006; 27:2099.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15945/abstract/34\">",
"      Wan C, Herzog CA, Zareba W, Szymkiewicz S. Improved Sudden Cardiac Arrest Survival in Hemodialysis Patients with Wearable Cardioverter Defibrillator. J Am Coll Cardiol 2012; 54:747.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1954 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-201.77.166.39-6F9A708CB0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_36_15945=[""].join("\n");
var outline_f15_36_15945=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      External defibrillators in the dialysis unit",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      General measures unique to dialysis patients",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Avoiding low potassium dialysate",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Nocturnal hemodialysis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Use of specific medications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      SECONDARY PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Implantable cardiac defibrillator",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - SCA during hemodialysis session",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Issues in ICD placement",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      PRIMARY PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Heart failure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Medical therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Implantable defibrillators",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2408037328\">",
"      - Wearable cardioverter-defibrillator",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Post-myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Medical therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Implantable cardiac defibrillator",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2408037361\">",
"      - Wearable cardioverter-defibrillator",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/1954\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/1954|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?6/40/6799\" title=\"figure 1\">",
"      Survival with ICD in dialysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?6/42/6830\" title=\"figure 2\">",
"      Survival of dialysis patients who received ICD devices",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/22/33134\" title=\"figure 3\">",
"      Dialysis patients with ICDs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?29/43/30398\" title=\"figure 4\">",
"      Comparison of ESRD patients receiving ICDs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?11/44/11983\" title=\"figure 5\">",
"      Survival of dialysis patients after ICDs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?11/24/11662\" title=\"figure 6\">",
"      Dialysis patients who received ICD devices",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/39/25208?source=related_link\">",
"      Automated external defibrillators",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/1/11288?source=related_link\">",
"      Evaluation of sudden cardiac arrest and sudden cardiac death in dialysis patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/24/4490?source=related_link\">",
"      Evaluation of the survivor of sudden cardiac arrest",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/46/20202?source=related_link\">",
"      Hypertension in dialysis patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/12/19657?source=related_link\">",
"      Implantable cardioverter-defibrillators: Clinical trials of primary prevention of sudden cardiac death",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/61/26584?source=related_link\">",
"      Myocardial dysfunction in end-stage renal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/21/30041?source=related_link\">",
"      Outcome of sudden cardiac arrest",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/55/890?source=related_link\">",
"      Overview of sudden cardiac arrest and sudden cardiac death",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/13/37082?source=related_link\">",
"      Patient survival and maintenance dialysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/62/15338?source=related_link\">",
"      Role of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death after myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/23/43385?source=related_link\">",
"      Role of implantable cardioverter-defibrillators for the secondary prevention of sudden cardiac death",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/24/8585?source=related_link\">",
"      Supportive data for advanced cardiac life support in adults with sudden cardiac arrest",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/16/264?source=related_link\">",
"      Technical aspects of nocturnal hemodialysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/12/9416?source=related_link\">",
"      Therapy of heart failure in hemodialysis patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/38/12905?source=related_link\">",
"      Use of beta blockers in heart failure due to systolic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/47/21241?source=related_link\">",
"      Ventricular arrhythmias in heart failure and cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/15/36088?source=related_link\">",
"      Wearable cardioverter-defibrillator",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f15_36_15946="Parkinson disease dementia";
var content_f15_36_15946=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Parkinson disease dementia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/36/15946/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/36/15946/contributors\">",
"     Robert L Rodnitzky, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/36/15946/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/36/15946/contributors\">",
"     Steven T DeKosky, MD, FAAN",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/36/15946/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/36/15946/contributors\">",
"     April F Eichler, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?15/36/15946/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 28, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cognitive dysfunction is common in Parkinson disease (PD). When severe, dementia often surpasses the motor features of PD as a major cause of disability and mortality.",
"   </p>",
"   <p>",
"    While PD can coexist with other common causes of dementia, such as Alzheimer disease and vascular dementia, dementia is increasingly recognized as a common feature of Parkinson disease itself. The clinical characteristics and course of dementia, its pathological features, and the most appropriate treatment are areas of current investigation. Clinical features can generally distinguish between PD and other movement disorders associated with dementia. However, whether PD dementia (PDD) and dementia with Lewy bodies (DLB) are distinct disorders, or whether they represent different presentations of the same disease, is an area of debate and investigation [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will discuss Parkinson disease dementia. Other aspects of Parkinson disease and dementia with Lewy bodies are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/13/14554?source=see_link\">",
"     \"Clinical manifestations of Parkinson disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/17/21784?source=see_link\">",
"     \"Management of comorbid problems associated with Parkinson disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/63/32762?source=see_link\">",
"     \"Pharmacologic treatment of Parkinson disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/41/34455?source=see_link\">",
"     \"Epidemiology, pathology, and pathogenesis of dementia with Lewy bodies\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1914?source=see_link\">",
"     \"Clinical features and diagnosis of dementia with Lewy bodies\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/34/21031?source=see_link\">",
"     \"Prognosis and treatment of dementia with Lewy bodies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dementia is a common feature of Parkinson disease (PD) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/2\">",
"     2",
"    </a>",
"    ]. In community-based studies of PD, the prevalence of dementia has been found to be as high as 41 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/3\">",
"     3",
"    </a>",
"    ]. A meta-analysis of 27 studies largely drawn from academic centers found a mean prevalence of 40 percent; however, this study did not distinguish Parkinson disease dementia (PDD) from dementia with Lewy bodies (DLB) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/4\">",
"     4",
"    </a>",
"    ]. In a review, using exacting criteria to identify 24 studies from the literature, 31 percent of 1767 PD patients were found to have dementia [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/5\">",
"     5",
"    </a>",
"    ]. In the same study, PD dementia was found to account for 3.6 percent of all cases of dementia in the population.",
"   </p>",
"   <p>",
"    Incidence rates may better describe the association of PD and dementia. In prospective cohort studies, incidence rates for dementia in patients with PD are consistently estimated at 95 to 107 per 1000 patient years, a rate almost five- to sixfold higher than controls [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. In different series, the cumulative incidence of dementia in PD was found to be as high as 78 percent in an eight-year follow-up study [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/8\">",
"     8",
"    </a>",
"    ] and, conditional on survival, 80 to 90 percent by age 90 years [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Older age, age at onset of PD &ge;60 years, duration of PD, and severity of parkinsonism may impact the incidence of dementia in PD [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/3,6-8,10-12\">",
"     3,6-8,10-12",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a community-based study, the prevalence of PD with dementia (PDD) in the general population was 787 per 100,000 for those &ge;80 years, while the prevalence for those &lt;50 years was zero [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a prospective, follow-up study evaluating the effect of disease duration, a 26 percent prevalence of dementia was noted at baseline in 224 patients with a mean disease duration of",
"      <span class=\"nowrap\">",
"       11/5",
"      </span>",
"      years [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/8\">",
"       8",
"      </a>",
"      ]. The prevalence of dementia was 52 percent four years later, and 78 percent eight years later. The mean PD duration at the onset of dementia in this study was 14 years.",
"     </li>",
"     <li>",
"      In a population-based study, 37 percent of patients whose PD began after the age 70 years were demented, compared with 9 percent of patients whose symptoms had begun before 70 years [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/12\">",
"       12",
"      </a>",
"      ]. After 5 years of follow-up, the prevalences had risen to 62 and 17 percent, respectively.",
"     </li>",
"     <li>",
"      In a population-based study, the relative risk (RR) for dementia was 9.7 in elderly (&ge;72 years), high-severity (Unified Parkinson Disease Rating Scale, UPDRS &gt;24) PD patients, compared with young, low-severity patients [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/13\">",
"       13",
"      </a>",
"      ]. Young, high-severity patients and elderly, low-severity patients were not at higher risk of dementia compared with the reference population, suggesting that age and PD severity interact to increase the risk of dementia.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Even patients with mild PD may suffer from cognitive impairment that does not meet criteria for dementia (see",
"    <a class=\"local\" href=\"#H9\">",
"     'Cognitive features'",
"    </a>",
"    below) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/14-17\">",
"     14-17",
"    </a>",
"    ]. Patients with subtle parkinsonian signs such as rigidity, but without a clinical diagnosis of PD, have been found to exhibit signs of amnestic mild cognitive impairment (MCI) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/14\">",
"     14",
"    </a>",
"    ]. In two studies of patients with a new diagnosis of PD, MCI was common, in 24 and 36 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. Older age and severity of motor parkinsonism correlated with cognitive impairment. The prognostic significance of these findings is not yet known. In one study, patients with PD and MCI had evidence of posterior cortical hypometabolism on positron emission tomography, compared to cognitively normal patients with PD and normal controls [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Genetic factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;There may also be genetic risk factors for the development of dementia in PD [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Siblings, but not parents, of patients with PDD were three times as likely to develop AD compared with normal subjects [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A rare hereditary syndrome of juvenile parkinsonism with dementia has been linked to a region on chromosome 1p and to a mutation in an ATPase gene [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Multiplication-type mutations of the alpha-synuclein gene have been identified in families with Parkinson disease and dementia [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Both the epsilon 2 (e2) and epsilon 4 (e4) alleles of the apolipoprotein gene have been implicated as possible risk factors for PDD [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/22-25\">",
"       22-25",
"      </a>",
"      ]. As an example, in a prospective cohort study of 212 patients with PD, the presence of the e4 allele was associated with more rapid cognitive decline [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/26\">",
"       26",
"      </a>",
"      ]. However, other studies and meta-analyses have found no or only modest associations between PDD and alleles of the apolipoprotein gene [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/27,28\">",
"       27,28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The gene encoding microtubule-associated protein tau (MAPT)",
"      <span class=\"nowrap\">",
"       H1/H2",
"      </span>",
"      has also been implicated in the development of PDD [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/29,30\">",
"       29,30",
"      </a>",
"      ]. In one cohort of 126 patients with PD, the MAPT",
"      <span class=\"nowrap\">",
"       H1/H1",
"      </span>",
"      genotype was strongly associated with incident dementia (OR=12.1) [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/29\">",
"       29",
"      </a>",
"      ]. In a subsequent study, this haplotype was noted to have a specific association with declining memory, but not the overall rate of cognitive decline [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     NEUROPATHOPHYSIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Neuropathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The anatomic and pathologic basis of Parkinson disease dementia (PDD) is not fully understood. Magnetic resonance imaging (MRI) and neuropathologic studies demonstrate more prominent global brain atrophy in PD patients with dementia than those without [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/31-34\">",
"     31-34",
"    </a>",
"    ]. Patients with PD without dementia have similar rates of brain atrophy as do controls. MRI studies have found that atrophy in patients with PDD is most prominent in limbic and paralimbic structures, including the hippocampus and the anterior cingulate gyrus [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/32,35\">",
"     32,35",
"    </a>",
"    ]. Another neuroimaging study found that patients with PDD have more white matter hyperintensities in the cholinergic pathways compare with cognitively intact patients with PD [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Neuropathologic staging in PD uses the observation that there is to some extent a relatively predictable neuroanatomic spread of Lewy body pathology. This is initially most prominent in the olfactory system and lower brainstem, then progresses to involve the midbrain structures. In later stages, other brain structures are involved, including the cortex. However, not all patients with PD and dementia have cortical Lewy body pathology [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/37\">",
"     37",
"    </a>",
"    ]. The neuropathologic stage of PD correlates with the severity of both motor parkinsonism and dementia [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the past, dementia in PDD has been attributed to coexisting Alzheimer and vascular pathology. However, neuropathologic studies have found that the degree of Lewy body pathology (Lewy bodies and Lewy neurites) correlates better with cognitive decline and dementia than does the degree of Alzheimer pathology, which may be relatively modest in these patients [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/39-45\">",
"     39-45",
"    </a>",
"    ]. Studies correlating dementia with neuropathology in PD note a potential critical role for nuclei, which project diffusely to cortical and subcortical areas, limbic structures, and the neocortex [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/41\">",
"     41",
"    </a>",
"    ]. Important exceptions are noted; some individuals have significant cognitive decline in the absence of cortical Lewy pathology, while others have normal cognitive function in the presence of widespread cortical pathology [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/38,46\">",
"     38,46",
"    </a>",
"    ]. A few studies have found that reduced amyloid beta (1-42) in the cerebrospinal fluid is associated with cognitive decline in patients with PD; as it is in other patient groups [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/33/27162?source=see_link&amp;anchor=H26#H26\">",
"     \"Clinical manifestations and diagnosis of Alzheimer disease\", section on 'Other laboratory testing'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/33/26138?source=see_link&amp;anchor=H9#H9\">",
"     \"Mild cognitive impairment: Prognosis and treatment\", section on 'CSF biomarkers'",
"    </a>",
"    .) It is likely that given the substantial prevalence of both AD and PD, that at least some patients with PD will have cognitive decline that is attributed to or exacerbated by AD [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Whether the neuropathology of PDD differs from that seen in dementia with Lewy bodies (DLB), or whether both conditions exist on a continuum is not clear; there are few comparative neuropathologic studies [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. Cortical Lewy bodies and Lewy neurites appear to substantially contribute to the pathologic substrate for dementia in both conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/49,51,52\">",
"     49,51,52",
"    </a>",
"    ]. One small study did find that neuronal loss in the substantia nigra was more significant in PDD than in DLB; other features including cortical Lewy pathology and Alzheimer pathology did not differ in PDD and DLB [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/53\">",
"     53",
"    </a>",
"    ]. In contrast, an evaluation of brain pathology in 57 patients with DLB or PDD found that a longer duration of parkinsonism prior to dementia was associated with more pronounced cortical cholinergic deficits and less severe cortical Lewy body pathology [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Neurotransmitter systems",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cognitive dysfunction in PD may be less a function of dopaminergic loss than are the motor symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/55\">",
"     55",
"    </a>",
"    ]. While some neuroimaging studies implicated fronto-striatal dopaminergic pathways [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/56\">",
"     56",
"    </a>",
"    ], dopaminergic medication has mild, heterogeneous effects on cognitive performance and may improve short-term memory early in the disease but not in more advanced patients [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H24\">",
"     'Treatment'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Cholinergic systems may be more important in the cognitive decline in PDD:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Loss of cholinergic neurons in the nucleus basalis of Meynert and decreased cholinergic activity in the cortex appears to be at least as significant in PDD as in AD [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/59-63\">",
"       59-63",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Anticholinergic drugs often exacerbate cognitive deficits in PD patients [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/64\">",
"       64",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Cholinesterase inhibitors modestly improve cognitive function in PDD (see",
"      <a class=\"local\" href=\"#H25\">",
"       'Cholinesterase inhibitors'",
"      </a>",
"      below)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other neurotransmitter systems may be involved in producing visual hallucinations. A positron emission tomography study found increased serotonin 2A receptor binding in nondemented PD patients with visual hallucinations compared to those without hallucinations [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Cognitive features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early signs of cognitive impairment in patients with Parkinson disease (PD) include executive dysfunction, visuospatial impairments, and verbal memory [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/15,66,67\">",
"     15,66,67",
"    </a>",
"    ]. As many as 26 to 34 percent of PD patients without dementia have been found to meet criteria for mild cognitive impairment [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/15,16,68\">",
"     15,16,68",
"    </a>",
"    ]. Tests of face recognition, in particular, are impaired early in the course of PD [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/66\">",
"     66",
"    </a>",
"    ]. Other measures of visuospatial function become impaired in more severe PD and are more impaired in those with, rather than without, dementia. All of these deficits may impair higher-level functioning well before patients meet criteria for dementia [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/69,70\">",
"     69,70",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The prognostic significance of these early findings has not been as well defined for PD dementia (PDD) as they have for mild cognitive impairment (MCI) and Alzheimer disease (AD) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/68,71\">",
"     68,71",
"    </a>",
"    ]. However, some studies suggest that early evidence of cognitive impairment in PD identifies a higher risk of future dementia [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/6,7,72\">",
"     6,7,72",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Executive dysfunction is a hallmark feature of PDD. This syndrome consists of deficiencies in set shifting, attention, and planning [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/73\">",
"     73",
"    </a>",
"    ]. In addition, visuospatial function appears disproportionately impaired in PDD compared with AD [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/66,74\">",
"     66,74",
"    </a>",
"    ]. Memory deficits, while less prominent than in AD, do occur in PDD but appear to be related to retrieval of learned information, which is improved by cuing. Conspicuously absent in PDD is aphasia, apraxia, and severe memory loss, features that are more common in AD.",
"   </p>",
"   <p>",
"    Comparison of neuropsychologic test profiles among patients with DLB, AD, and PDD revealed no differences between DLB and PDD [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/75,76\">",
"     75,76",
"    </a>",
"    ]. AD patients were more likely to have significant impairment on memory testing, while patients with PDD and DLB were more likely to have visuoperceptive, visuoconstructive, and attentional deficits [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/75,77\">",
"     75,77",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Neuropsychiatric features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Visual hallucinations are common in PD with and without dementia and can be identified in as many as 50 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/78,79\">",
"     78,79",
"    </a>",
"    ]. The presence of visual hallucinations is strongly associated with cognitive dysfunction and to a lesser extent with rigidity and autonomic dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/80\">",
"     80",
"    </a>",
"    ]. A variety of antiParkinson drugs, most notably anticholinergic agents, dopaminergic agents, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/46/13031?source=see_link\">",
"     amantadine",
"    </a>",
"    , can exacerbate visual hallucinations. In nondemented PD patients, those with hallucinations are more likely to develop dementia than are patients without this symptom [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/6,8,10,81\">",
"     6,8,10,81",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other manifestations of psychosis in PD include delusions, often paranoid and related to spousal infidelity and persecution. These also may be exacerbated by antiparkinsonian drugs. The neuropsychiatric features of PD are discussed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/17/21784?source=see_link&amp;anchor=H2#H2\">",
"     \"Management of comorbid problems associated with Parkinson disease\", section on 'Psychosis and hallucinations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    PD patients with and without dementia are also subject to depression, anxiety, and sleep disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/79\">",
"     79",
"    </a>",
"    ]. Depression occurs in 30 to 40 percent and correlates poorly with degree of motor impairment, but may be predictive of cognitive decline [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/50,82\">",
"     50,82",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/13/14554?source=see_link&amp;anchor=H12#H12\">",
"     \"Clinical manifestations of Parkinson disease\", section on 'Mood disorders'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Sleep disorders include sleep fragmentation, nightmares, and REM sleep behavior disorder. The latter is a parasomnia characterized by vivid dreams in REM sleep without the usual accompanying muscle atonia. This causes individuals to \"act out\" their dreams, especially when they are vivid or frightening. REM sleep behavior disorder is somewhat more common in DLB, but occurs in 15 to 30 percent of patients with PD with or without dementia [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/83\">",
"     83",
"    </a>",
"    ]. In nondemented PD patients, REM sleep disorder is associated with cognitive impairment [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/84,85\">",
"     84,85",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1914?source=see_link&amp;anchor=H9#H9\">",
"     \"Clinical features and diagnosis of dementia with Lewy bodies\", section on 'REM sleep disorder'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/13/14554?source=see_link&amp;anchor=H16#H16\">",
"     \"Clinical manifestations of Parkinson disease\", section on 'Sleep disorders'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Cardinal motor features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Core motor features of Parkinson disease include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Brady- and akinesia",
"     </li>",
"     <li>",
"      Rigidity",
"     </li>",
"     <li>",
"      Resting tremor",
"     </li>",
"     <li>",
"      Postural instability",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Resting tremor is more specific to PD than are other parkinsonian features; however, PD patients with tremor as their predominant motor symptom are less likely to develop cognitive impairment than are those with more prominent postural instability and gait impairment [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/86-88\">",
"     86-88",
"    </a>",
"    ]. Another characteristic of PD is the asymmetry of motor features early in the disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/13/14554?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical manifestations of Parkinson disease\", section on 'Cardinal manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Other features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other signs of neurologic impairment are prevalent in patients with Parkinson disease. These are summarized in the tables (",
"    <a class=\"graphic graphic_table graphicRef81338 \" href=\"UTD.htm?21/3/21564\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef71879 \" href=\"UTD.htm?3/44/3787\">",
"     table 2",
"    </a>",
"    ) and discussed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/13/14554?source=see_link\">",
"     \"Clinical manifestations of Parkinson disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Clinical course",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dementia typically occurs in the last half of the clinical course of PD, whereas it is often one of the presenting features of DLB. Similarly, hallucinations are a late-appearing consequence of PD or PDD but are seen early in the course of DLB and may be among the presenting features of the illness. In one follow-up study, those patients with PD who developed cognitive impairment declined by an average 2.4 points per year on the mini-mental state examination [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Parkinson disease dementia (PDD) is one of a number of conditions that include dementia and parkinsonism as prominent features.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Dementia with Lewy bodies",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differentiation of PDD and Dementia with Lewy bodies (DLB) is somewhat arbitrary. In PDD, dementia occurs in the setting of well-established parkinsonism, while in DLB, dementia usually occurs before, at the same time, or very shortly after the development of parkinsonian signs. If parkinsonism is present for more than one year before the onset of dementia, it is officially classified as PDD. This arbitrary \"one year rule\" may be an artificial distinction; the length of time that parkinsonism precedes other symptoms in otherwise similar patients does not correlate with pathologic differences [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/89\">",
"     89",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other features that may help distinguish between PDD and DLB are a faster clinical decline and decreased levodopa responsivity for DLB compared with PDD [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/90\">",
"     90",
"    </a>",
"    ]. Parkinsonian features are more likely to be bilaterally asymmetric and more severe in PDD according to most, although not all, studies [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/91\">",
"     91",
"    </a>",
"    ]. Tremor is more common in PDD than DLB [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/92\">",
"     92",
"    </a>",
"    ]. Significant fluctuations in cognition are common in DLB, but rarely occur in PDD.",
"   </p>",
"   <p>",
"    In one study, volumetric analysis of MRI scans found that patients with DLB had more pronounced cortical atrophy than did patients with Parkinson disease dementia (PDD) despite having a similar severity of clinical dementia [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/93\">",
"     93",
"    </a>",
"    ]. Another study also found that patients with PDD and DLB with similar severities of dementia could be distinguished by patterns of fractional anisotropy on diffuse tensor imaging MRI [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/94\">",
"     94",
"    </a>",
"    ]. However, it seems unlikely that these observations are sufficiently sensitive and specific to aid in diagnosis of DLB versus PDD in individual patients [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/95\">",
"     95",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite these observed clinical trends, no individual symptom characteristic or test finding reliably distinguishes the motor parkinsonism of PD versus DLB. It remains uncertain even whether these are distinct disorders. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1914?source=see_link\">",
"     \"Clinical features and diagnosis of dementia with Lewy bodies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Progressive supranuclear palsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Progressive supranuclear palsy (PSP) is a rare syndrome that can mimic PDD early on. Distinctive early features of this disorder include a vertical supranuclear gaze palsy and prominent postural instability with falls [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/96,97\">",
"     96,97",
"    </a>",
"    ]. The response to levodopa is typically poor, but about 20 percent of patients may have some improvement with L-dopa in early stages of the disease [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/96\">",
"     96",
"    </a>",
"    ]. Bradykinesia and rigidity are typically symmetric in onset [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/98\">",
"     98",
"    </a>",
"    ]. Behavioral changes: apathy, disinhibition, dysphoria, and anxiety are common [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/99\">",
"     99",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/30/26089?source=see_link&amp;anchor=H7#H7\">",
"     \"Diagnosis of Parkinson disease\", section on 'Progressive supranuclear palsy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Multiple systems atrophy",
"    </span>",
"    &nbsp;&mdash;&nbsp;An umbrella term for olivopontocerebellar atrophy, striatonigral degeneration, and Shy-Drager syndrome, multiple systems atrophy (MSA) commonly presents with parkinsonism. Other features can include dysautonomia, cerebellar ataxia, and corticospinal tract deficits. The prominence of these manifestations and the symmetry of onset, absence of tremor, and poor response to levodopa suggest this diagnosis rather than PDD [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/100\">",
"     100",
"    </a>",
"    ]. Traditionally, the dementia of MSA has been thought to be milder than that seen in PSP or corticobasal degeneration [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/101\">",
"     101",
"    </a>",
"    ]; however a large prospective cohort of patients with PSP and MSA found that dementia, while slightly less common in MSA, was no less severe [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/102\">",
"     102",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Corticobasal degeneration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with this condition (CBD, also referred to as corticobasal syndrome (CBS) when neuropathologic confirmation is lacking) can have asymmetric parkinsonism including bradykinesia, rigidity, and postural instability. More distinctive features can include ideomotor apraxia, alien limb phenomenon, aphasia, and loss of cortical sensory function [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/100\">",
"     100",
"    </a>",
"    ]. Absence of tremor and lack of levodopa response are typical for CBD and help to distinguish it from PDD. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/14/5354?source=see_link\">",
"     \"Corticobasal degeneration\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Alzheimer disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although subtle extrapyramidal signs may be present in early stages of Alzheimer disease (AD), clinically-evident parkinsonism does not develop until late stage AD [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/103\">",
"     103",
"    </a>",
"    ]. In most cases, the relative timing of the appearance of dementia and parkinsonism is obvious, such that this feature, in itself, does not confuse AD and PDD.",
"   </p>",
"   <p>",
"    Alternatively, AD may develop in a patient with PD, as the two disorders are not rare. This might be hard to distinguish from PDD early on, but the ultimate appearance of cortical dysfunction, such as aphasia or apraxia, or a profound amnesic syndrome usually suggests the presence of the second dementing condition. Prominent neuropsychiatric symptoms, however, suggest that the dementia is due to PDD rather than AD [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/81\">",
"     81",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Cerebrovascular disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infarctions in multiple vascular territories affecting periventricular and subcortical white matter, basal ganglia, and brainstem can produce dementia and a vascular parkinsonism. An abrupt onset of symptoms, predominant involvement of the lower extremities, a stepwise course, vascular risk factors, focal neurologic signs, pseudobulbar palsy, and evidence of vascular disease on neuroimaging suggest this diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/57/37786?source=see_link\">",
"     \"Etiology, clinical manifestations, and diagnosis of vascular dementia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Other considerations",
"    </span>",
"    &nbsp;&mdash;&nbsp;When cognitive impairment occurs in the setting of Parkinson disease, clinicians should consider possibilities other than dementia. Depression and other neuropsychiatric symptoms are common in PD and may contribute to cognitive impairment. Motor impairments of PD, particularly physical inactivity and bradyphrenia, may lead to the appearance of dementia. Similarly, patients with PD should be screened for causes of delirium that can lead to superimposed cognitive impairment, usually presenting more acutely and with altered sensorium.",
"   </p>",
"   <p>",
"    Patients with Alzheimer disease or other dementias may be treated with neuroleptic drugs associated with extrapyramidal side effects.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/11/25785?source=see_link\">",
"     Valproate",
"    </a>",
"    also has been associated with a syndrome of reversible parkinsonism and cognitive decline. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/61/43994?source=see_link&amp;anchor=H19#H19\">",
"     \"Pharmacology of antiepileptic drugs\", section on 'Valproate'",
"    </a>",
"    .) Because medication effects can be prolonged, even for a year or more, after medication discontinuation, a complete history of medication use should be elicited [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/100\">",
"     100",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation of a patient with dementia first establishes the presence of cognitive impairment and provides a measure of its severity. The mini mental state exam (MMSE) cannot be solely relied upon to detect disabling cognitive impairment in Parkinson disease dementia (PDD) because it is not very sensitive to executive dysfunction, a key feature of PDD (see",
"    <a class=\"local\" href=\"#H9\">",
"     'Cognitive features'",
"    </a>",
"    above). The Montreal Cognitive Assessment (MOCA) has been found tobe a more accurate brief bedside test for PDD [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/104\">",
"     104",
"    </a>",
"    ]. Neuropsychologic testing is more sensitive for defining cognitive impairments.",
"   </p>",
"   <p>",
"    Treatable causes of cognitive impairment and dementia should be excluded [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/2\">",
"     2",
"    </a>",
"    ]. In general, this evaluation includes a neuroimaging study (usually magnetic resonance imaging), and laboratory evaluations (eg, vitamin B12 level and thyroid function tests). This topic is discussed in more detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/25/28057?source=see_link\">",
"     \"Evaluation of cognitive impairment and dementia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Because of the frequent comorbidity of depression in PD, screening for depression as an alternative cause or a contributor to cognitive impairment is recommended. The Beck Depression Inventory, Hamilton Depression Rating Scale, and the Montgomery Asberg Depression Rating scale have all had demonstrated utility in this setting [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/105-108\">",
"     105-108",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are no published clinical criteria for PDD as there are for dementia with Lewy bodies (DLB). The diagnosis of PDD is primarily based upon clinical history and examination, in which the diagnosis of dementia is made in the setting of established parkinsonism (of at least one year), and other diagnoses are excluded. There are no specific findings on either neuroimaging, neuropsychologic testing, or laboratory results that are useful in the positive diagnosis of PDD. While some neuropsychologic test features are more suggestive of PDD versus AD, their sensitivity and specificity is not defined, and at present there is little clinical imperative to make this distinction [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/101\">",
"     101",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dementia in Parkinson disease is associated with reduced patient and caregiver quality of life, reduced survival, increased risks of nursing home admission, and other neuropsychiatric symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/6,12,22,105,109-112\">",
"     6,12,22,105,109-112",
"    </a>",
"    ]. Among a cohort of 180 patients with PD not demented at baseline, incident dementia was associated with a twofold increase in mortality over a mean four-year follow-up, even after controlling for severity of motor symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/110\">",
"     110",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of Parkinson disease dementia (PDD) is symptomatic. No therapies have been shown to modify the course of the disease or influence prognosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Cholinesterase inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of dementia in PD centers on the use of cholinesterase inhibitors (CIs) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/113\">",
"     113",
"    </a>",
"    ]. Most, but not all, studies of CIs in PDD have noted a mild to moderate benefit [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/113-121\">",
"     113-121",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/26/6567?source=see_link\">",
"       Rivastigmine",
"      </a>",
"      was evaluated in a 24-week, double-blind, placebo-controlled study of 501 patients with mild to moderate PDD and was found to result in moderate improvement in dementia, mean improvement of 2.1 points on the Alzheimer disease Assessment Scale-Cognitive Subscale (ADAS-cog) score compared with 0.7 point decline in the placebo-treated group [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/114\">",
"       114",
"      </a>",
"      ]. Clinically meaningful improvements were seen in 20 and 14.5 percent in the treatment and placebo groups, respectively, while clinically meaningful worsening was observed in 13 and 23 percent. This suggests that overall, 15 percent of patients benefited from treatment [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/115\">",
"       115",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/30/10726?source=see_link\">",
"       Donepezil",
"      </a>",
"      therapy was evaluated in a randomized study of 550 patients with PDD [",
"      <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/121\">",
"       121",
"      </a>",
"      ]. After 24 week, active therapy was associated with significant benefit on the ADAS-cog score but not when the analysis was performed using the predefined statistical model that included a treatment-by-country interaction term. Donepezil also appeared to be associated with benefit by other, although not all, primary and secondary outcome measures.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Another potential benefit of CIs in PDD is improvement in neuropsychiatric symptoms, such as hallucinations. While this benefit has been inconsistently observed in studies, increased dropouts due to worsened tremor, nausea, and vomiting were also reported [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/114,119,120\">",
"     114,119,120",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27402?source=see_link&amp;anchor=H18#H18\">",
"     \"Treatment of behavioral symptoms related to dementia\", section on 'Cholinesterase inhibitors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Because of the presence of a modest benefit for acetylcholinesterase inhibitors, we suggest their use in PDD if the patient does not experience intolerable side effects. A more detailed discussion of the use of cholinesterase inhibitors in dementia is found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1913?source=see_link\">",
"     \"Cholinesterase inhibitors in the treatment of dementia\"",
"    </a>",
"    .) When cholinesterase inhibitors are discontinued, they should not be abruptly terminated, if at all possible, but rather tapered to avoid sudden cognitive and behavioral worsening [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/122\">",
"     122",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Memantine",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/16/24837?source=see_link\">",
"     Memantine",
"    </a>",
"    has reported efficacy in moderate to severe AD and in vascular dementia. One 24-week randomized controlled study of 72 patients with either DLB or PDD found that patients treated with memantine performed better on the primary outcome assessment measure, the clinical global impression of change, but not on other secondary outcome measures [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/123\">",
"     123",
"    </a>",
"    ]. In a more recent, 24-week randomized controlled study, DLB patients, but not PDD patients, were improved on the same outcome measure [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/124\">",
"     124",
"    </a>",
"    ]. Memantine was well-tolerated in these trials and in another shorter study of patients with PDD [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/125\">",
"     125",
"    </a>",
"    ]. However, hallucinations and worsened neuropsychiatric symptoms have occasionally been reported with the use of memantine, suggesting some caution with its use in PDD [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/126-128\">",
"     126-128",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Psychosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Visual hallucinations and other psychotic features can be treated with atypical antipsychotic agents. Some caution should be employed with these agents because of the risk of motor side effects in this population. Severe side effects, while not as common as in dementia with Lewy bodies, do occur in a substantial portion of patients with PDD [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/129\">",
"     129",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1914?source=see_link&amp;anchor=H10#H10\">",
"     \"Clinical features and diagnosis of dementia with Lewy bodies\", section on 'Neuroleptic sensitivity'",
"    </a>",
"    .) Doses should be started at the lowest possible and titrated upward gradually.",
"   </p>",
"   <p>",
"    Among the atypical antipsychotic agents,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/21/35161?source=see_link\">",
"     clozapine",
"    </a>",
"    has the best established utility, with an extremely low risk of exacerbating parkinsonism, but has a risk of fatal agranulocytosis, requiring rigorous monitoring of the white blood cell count [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/105,106\">",
"     105,106",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/56/20361?source=see_link\">",
"     Quetiapine",
"    </a>",
"    is also effective and has a more acceptable side effect profile [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/130,131\">",
"     130,131",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/36/37449?source=see_link\">",
"     Olanzapine",
"    </a>",
"    doesn't clearly improve psychosis and may worsen motor symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/105\">",
"     105",
"    </a>",
"    ]. Older, so-called conventional antipsychotic agents are much more likely to exacerbate motor parkinsonism and should be avoided in PDD. This topic is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/17/21784?source=see_link&amp;anchor=H2#H2\">",
"     \"Management of comorbid problems associated with Parkinson disease\", section on 'Psychosis and hallucinations'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27402?source=see_link\">",
"     \"Treatment of behavioral symptoms related to dementia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Motor parkinsonism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of motor parkinsonian symptoms is similar in PD with and without dementia. However, patients with PDD may be particularly susceptible to the neuropsychiatric side effects of dopaminergic medications; these may be dose limiting",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    require concomitant use of antipsychotic agents. Observational studies suggest that L-dopa does not adversely affect cognition overall [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/132\">",
"     132",
"    </a>",
"    ]; however, in other studies, dopaminergic therapy has been shown to have beneficial effects on some specific cognitive measures and detrimental effects on others [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/133,134\">",
"     133,134",
"    </a>",
"    ]. Individual baseline cognition and learning style may modulate the effect of dopamine as well [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/135\">",
"     135",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Anticholinergic agents frequently exacerbate cognitive impairment and are generally avoided in patients with PDD. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/63/32762?source=see_link&amp;anchor=H2#H2\">",
"     \"Pharmacologic treatment of Parkinson disease\", section on 'Symptomatic therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with PDD are generally excluded from consideration for deep brain stimulation (DBS) therapy because of poor outcomes. As an example, in a study of 41 patients evaluated after suboptimal response to DBS, 20 percent of these patients had preoperative dementia [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/136\">",
"     136",
"    </a>",
"    ]. On the other hand, in PD patients with mild or no dementia, accumulated evidence suggests that bilateral subthalamic DBS can result in small declines in measures of executive function and a moderate decline in verbal fluency [",
"    <a class=\"abstract\" href=\"UTD.htm?15/36/15946/abstract/137\">",
"     137",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?13/40/13954?source=see_link\">",
"       \"Patient information: Parkinson disease (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?14/37/14934?source=see_link\">",
"       \"Patient information: Dementia (including Alzheimer disease) (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?5/4/5188?source=see_link\">",
"       \"Patient information: Parkinson disease symptoms and diagnosis (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cognitive dysfunction and dementia are common in Parkinson disease (PD).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The risk of dementia in patients with PD increases with age of onset, age of the patient, duration, and severity of the illness. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Neuropathologic studies suggest that Lewy body pathology rather than coincident Alzheimer or cerebrovascular disease is responsible for dementia in most patients with PDD (PD dementia). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Neuropathophysiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The cognitive dysfunction of PDD is distinct from Alzheimer disease. With PDD, memory impairment is less prominent early on, while executive dysfunction and visual spatial impairments are features that may be apparent and functionally limiting before the patient meets criteria for dementia. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Cognitive features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other disorders that produce dementia and parkinsonism include dementia with Lewy bodies (DLB), progressive supranuclear palsy, multiple systems atrophy, and corticobasal degeneration. PDD is distinguished from DLB by the onset of dementia in the setting of well-established parkinsonism of at least one year's duration. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of PDD is made by the determination of dementia in a patient with typical, well-established PD of at least one year's duration. Neuropsychological testing may aid in the diagnosis of dementia; laboratory studies and neuroimaging are performed to exclude other conditions. The mini mental state exam (MMSE) cannot be solely relied upon to detect disabling cognitive impairment in PDD because it is not very sensitive to executive dysfunction. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest the use of cholinesterase inhibitors in patients with PDD (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). These appear to confer a modest benefit for cognition in patients with PDD; evidence for improved neuropsychiatric symptoms is less convincing. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Cholinesterase inhibitors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with PDD may be more susceptible to neuropsychiatric side effects of antiparkinson medications. This may be dose limiting. We suggest avoiding anticholinergic medications in patients with PDD. We recommend using low-dose",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/56/20361?source=see_link\">",
"       quetiapine",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/21/35161?source=see_link\">",
"       clozapine",
"      </a>",
"      for treatment of psychosis when necessary (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Clozapine requires rigorous white blood cell monitoring. We recommend avoiding the use of older, conventional antipsychotics, which are known to exacerbate motor parkinsonism. (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Psychosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The treatment of motor parkinsonism is similar to that for the patient with PD without dementia. An exception is that dementia is a relative contraindication for deep brain stimulation therapy. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/1\">",
"      Lippa CF, Duda JE, Grossman M, et al. DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology 2007; 68:812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/2\">",
"      Svenningsson P, Westman E, Ballard C, Aarsland D. Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment. Lancet Neurol 2012; 11:697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/3\">",
"      Mayeux R, Denaro J, Hemenegildo N, et al. A population-based investigation of Parkinson's disease with and without dementia. Relationship to age and gender. Arch Neurol 1992; 49:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/4\">",
"      Cummings JL. Intellectual impairment in Parkinson's disease: clinical, pathologic, and biochemical correlates. J Geriatr Psychiatry Neurol 1988; 1:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/5\">",
"      Aarsland D, Zaccai J, Brayne C. A systematic review of prevalence studies of dementia in Parkinson's disease. Mov Disord 2005; 20:1255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/6\">",
"      Hobson P, Meara J. Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom. Mov Disord 2004; 19:1043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/7\">",
"      Aarsland D, Andersen K, Larsen JP, et al. Risk of dementia in Parkinson's disease: a community-based, prospective study. Neurology 2001; 56:730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/8\">",
"      Aarsland D, Andersen K, Larsen JP, et al. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 2003; 60:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/9\">",
"      Buter TC, van den Hout A, Matthews FE, et al. Dementia and survival in Parkinson disease: a 12-year population study. Neurology 2008; 70:1017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/10\">",
"      Stern Y, Marder K, Tang MX, Mayeux R. Antecedent clinical features associated with dementia in Parkinson's disease. Neurology 1993; 43:1690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/11\">",
"      Hughes TA, Ross HF, Musa S, et al. A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease. Neurology 2000; 54:1596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/12\">",
"      Reid WG, Hely MA, Morris JG, et al. A longitudinal of Parkinson's disease: clinical and neuropsychological correlates of dementia. J Clin Neurosci 1996; 3:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/13\">",
"      Levy G, Schupf N, Tang MX, et al. Combined effect of age and severity on the risk of dementia in Parkinson's disease. Ann Neurol 2002; 51:722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/14\">",
"      Louis ED, Schupf N, Manly J, et al. Association between mild parkinsonian signs and mild cognitive impairment in a community. Neurology 2005; 64:1157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/15\">",
"      Muslimovic D, Post B, Speelman JD, Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005; 65:1239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/16\">",
"      Foltynie T, Brayne CE, Robbins TW, Barker RA. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain 2004; 127:550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/17\">",
"      Poletti M, Frosini D, Pagni C, et al. Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2012; 83:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/18\">",
"      Pappat&agrave; S, Santangelo G, Aarsland D, et al. Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism. Neurology 2011; 77:1357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/19\">",
"      Marder K, Tang MX, Alfaro B, et al. Risk of Alzheimer's disease in relatives of Parkinson's disease patients with and without dementia. Neurology 1999; 52:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/20\">",
"      Ramirez A, Heimbach A, Gr&uuml;ndemann J, et al. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet 2006; 38:1184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/21\">",
"      Obi T, Nishioka K, Ross OA, et al. Clinicopathologic study of a SNCA gene duplication patient with Parkinson disease and dementia. Neurology 2008; 70:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/22\">",
"      de Lau LM, Schipper CM, Hofman A, et al. Prognosis of Parkinson disease: risk of dementia and mortality: the Rotterdam Study. Arch Neurol 2005; 62:1265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/23\">",
"      Pankratz N, Byder L, Halter C, et al. Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia. Mov Disord 2006; 21:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/24\">",
"      Harhangi BS, de Rijk MC, van Duijn CM, et al. APOE and the risk of PD with or without dementia in a population-based study. Neurology 2000; 54:1272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/25\">",
"      Huang X, Chen P, Kaufer DI, et al. Apolipoprotein E and dementia in Parkinson disease: a meta-analysis. Arch Neurol 2006; 63:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/26\">",
"      Morley JF, Xie SX, Hurtig HI, et al. Genetic influences on cognitive decline in Parkinson's disease. Mov Disord 2012; 27:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/27\">",
"      Jasinska-Myga B, Opala G, Goetz CG, et al. Apolipoprotein E gene polymorphism, total plasma cholesterol level, and Parkinson disease dementia. Arch Neurol 2007; 64:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/28\">",
"      Williams-Gray CH, Goris A, Saiki M, et al. Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease. J Neurol 2009; 256:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/29\">",
"      Williams-Gray CH, Evans JR, Goris A, et al. The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain 2009; 132:2958.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/30\">",
"      Goris A, Williams-Gray CH, Clark GR, et al. Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease. Ann Neurol 2007; 62:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/31\">",
"      Burton EJ, McKeith IG, Burn DJ, O'Brien JT. Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging. Mov Disord 2005; 20:1571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/32\">",
"      Nagano-Saito A, Washimi Y, Arahata Y, et al. Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology 2005; 64:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/33\">",
"      Beyer MK, Janvin CC, Larsen JP, Aarsland D. A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry. J Neurol Neurosurg Psychiatry 2007; 78:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/34\">",
"      Melzer TR, Watts R, MacAskill MR, et al. Grey matter atrophy in cognitively impaired Parkinson's disease. J Neurol Neurosurg Psychiatry 2012; 83:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/35\">",
"      Carlesimo GA, Piras F, Assogna F, et al. Hippocampal abnormalities and memory deficits in Parkinson disease: a multimodal imaging study. Neurology 2012; 78:1939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/36\">",
"      Shin J, Choi S, Lee JE, et al. Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive status. J Neurol Neurosurg Psychiatry 2012; 83:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/37\">",
"      Parkkinen L, Pirttil&auml; T, Alafuzoff I. Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance. Acta Neuropathol 2008; 115:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/38\">",
"      Braak H, R&uuml;b U, Jansen Steur EN, et al. Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 2005; 64:1404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/39\">",
"      Aarsland D, Perry R, Brown A, et al. Neuropathology of dementia in Parkinson's disease: a prospective, community-based study. Ann Neurol 2005; 58:773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/40\">",
"      Apaydin H, Ahlskog JE, Parisi JE, et al. Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. Arch Neurol 2002; 59:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/41\">",
"      K&ouml;vari E, Gold G, Herrmann FR, et al. Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease. Acta Neuropathol 2003; 106:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/42\">",
"      Edison P, Rowe CC, Rinne JO, et al. Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. J Neurol Neurosurg Psychiatry 2008; 79:1331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/43\">",
"      Petrou M, Bohnen NI, M&uuml;ller ML, et al. A&beta;-amyloid deposition in patients with Parkinson disease at risk for development of dementia. Neurology 2012; 79:1161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/44\">",
"      Kotzbauer PT, Cairns NJ, Campbell MC, et al. Pathologic accumulation of &alpha;-synuclein and A&beta; in Parkinson disease patients with dementia. Arch Neurol 2012; 69:1326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/45\">",
"      Irwin DJ, White MT, Toledo JB, et al. Neuropathologic substrates of Parkinson disease dementia. Ann Neurol 2012; 72:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/46\">",
"      Colosimo C, Hughes AJ, Kilford L, Lees AJ. Lewy body cortical involvement may not always predict dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 2003; 74:852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/47\">",
"      Siderowf A, Xie SX, Hurtig H, et al. CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease. Neurology 2010; 75:1055.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/48\">",
"      Alves G, Br&oslash;nnick K, Aarsland D, et al. CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry 2010; 81:1080.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/49\">",
"      Rahkonen T, Eloniemi-Sulkava U, Rissanen S, et al. Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older. J Neurol Neurosurg Psychiatry 2003; 74:720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/50\">",
"      McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47:1113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/51\">",
"      Stevens T, Livingston G, Kitchen G, et al. Islington study of dementia subtypes in the community. Br J Psychiatry 2002; 180:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/52\">",
"      Mori H. Pathological substrate of dementia in Parkinson's disease--its relation to DLB and DLBD. Parkinsonism Relat Disord 2005; 11 Suppl 1:S41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/53\">",
"      Tsuboi Y, Dickson DW. Dementia with Lewy bodies and Parkinson's disease with dementia: are they different? Parkinsonism Relat Disord 2005; 11 Suppl 1:S47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/54\">",
"      Ballard C, Ziabreva I, Perry R, et al. Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology 2006; 67:1931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/55\">",
"      Press DZ, Mechanic DJ, Tarsy D, Manoach DS. Cognitive slowing in Parkinson's disease resolves after practice. J Neurol Neurosurg Psychiatry 2002; 73:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/56\">",
"      Ekman U, Eriksson J, Forsgren L, et al. Functional brain activity and presynaptic dopamine uptake in patients with Parkinson's disease and mild cognitive impairment: a cross-sectional study. Lancet Neurol 2012; 11:679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/57\">",
"      Marini P, Ramat S, Ginestroni A, Paganini M. Deficit of short-term memory in newly diagnosed untreated parkinsonian patients: reversal after L-dopa therapy. Neurol Sci 2003; 24:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/58\">",
"      Morrison CE, Borod JC, Brin MF, et al. Effects of levodopa on cognitive functioning in moderate-to-severe Parkinson's disease (MSPD). J Neural Transm 2004; 111:1333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/59\">",
"      Perry EK, Curtis M, Dick DJ, et al. Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. J Neurol Neurosurg Psychiatry 1985; 48:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/60\">",
"      Mattila PM, R&ouml;ytt&auml; M, L&ouml;nnberg P, et al. Choline acetytransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment. Acta Neuropathol 2001; 102:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/61\">",
"      Bohnen NI, Kaufer DI, Ivanco LS, et al. Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Arch Neurol 2003; 60:1745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/62\">",
"      Bohnen NI, Kaufer DI, Hendrickson R, et al. Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia. J Neurol 2006; 253:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/63\">",
"      Shimada H, Hirano S, Shinotoh H, et al. Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET. Neurology 2009; 73:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/64\">",
"      Ehrt U, Broich K, Larsen JP, et al. Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study. J Neurol Neurosurg Psychiatry 2010; 81:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/65\">",
"      Ballanger B, Strafella AP, van Eimeren T, et al. Serotonin 2A receptors and visual hallucinations in Parkinson disease. Arch Neurol 2010; 67:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/66\">",
"      Levin BE, Llabre MM, Reisman S, et al. Visuospatial impairment in Parkinson's disease. Neurology 1991; 41:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/67\">",
"      Aarsland D, Br&oslash;nnick K, Larsen JP, et al. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study. Neurology 2009; 72:1121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/68\">",
"      Aarsland D, Bronnick K, Williams-Gray C, et al. Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 2010; 75:1062.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/69\">",
"      Uc EY, Rizzo M, Anderson SW, et al. Visual dysfunction in Parkinson disease without dementia. Neurology 2005; 65:1907.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/70\">",
"      Bronnick K, Ehrt U, Emre M, et al. Attentional deficits affect activities of daily living in dementia-associated with Parkinson's disease. J Neurol Neurosurg Psychiatry 2006; 77:1136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/71\">",
"      Emre M. Dementia in Parkinson's disease: cause and treatment. Curr Opin Neurol 2004; 17:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/72\">",
"      Taylor JP, Rowan EN, Lett D, et al. Poor attentional function predicts cognitive decline in patients with non-demented Parkinson's disease independent of motor phenotype. J Neurol Neurosurg Psychiatry 2008; 79:1318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/73\">",
"      Raskin SA, Borod JC, Tweedy J. Neuropsychological aspects of Parkinson's disease. Neuropsychol Rev 1990; 1:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/74\">",
"      Stern Y, Richards M, Sano M, Mayeux R. Comparison of cognitive changes in patients with Alzheimer's and Parkinson's disease. Arch Neurol 1993; 50:1040.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/75\">",
"      Noe E, Marder K, Bell KL, et al. Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia. Mov Disord 2004; 19:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/76\">",
"      Ballard CG, Aarsland D, McKeith I, et al. Fluctuations in attention: PD dementia vs DLB with parkinsonism. Neurology 2002; 59:1714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/77\">",
"      Bronnick K, Emre M, Lane R, et al. Profile of cognitive impairment in dementia associated with Parkinson's disease compared with Alzheimer's disease. J Neurol Neurosurg Psychiatry 2007; 78:1064.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/78\">",
"      Williams DR, Lees AJ. Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study. Lancet Neurol 2005; 4:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/79\">",
"      Aarsland D, Br&oslash;nnick K, Ehrt U, et al. Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress. J Neurol Neurosurg Psychiatry 2007; 78:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/80\">",
"      F&eacute;nelon G, Mahieux F, Huon R, Zi&eacute;gler M. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain 2000; 123 ( Pt 4):733.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/81\">",
"      Galvin JE, Pollack J, Morris JC. Clinical phenotype of Parkinson disease dementia. Neurology 2006; 67:1605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/82\">",
"      Kandiah N, Narasimhalu K, Lau PN, et al. Cognitive decline in early Parkinson's disease. Mov Disord 2009; 24:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/83\">",
"      Paparrigopoulos TJ. REM sleep behaviour disorder: clinical profiles and pathophysiology. Int Rev Psychiatry 2005; 17:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/84\">",
"      Vendette M, Gagnon JF, D&eacute;cary A, et al. REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia. Neurology 2007; 69:1843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/85\">",
"      Gagnon JF, Vendette M, Postuma RB, et al. Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease. Ann Neurol 2009; 66:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/86\">",
"      Burn DJ, Rowan EN, Allan LM, et al. Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2006; 77:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/87\">",
"      Burn DJ, Rowan EN, Minett T, et al. Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross-sectional comparative study. Mov Disord 2003; 18:884.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/88\">",
"      Verbaan D, Marinus J, Visser M, et al. Cognitive impairment in Parkinson's disease. J Neurol Neurosurg Psychiatry 2007; 78:1182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/89\">",
"      McKeith I, Mintzer J, Aarsland D, et al. Dementia with Lewy bodies. Lancet Neurol 2004; 3:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/90\">",
"      Molloy S, McKeith IG, O'Brien JT, Burn DJ. The role of levodopa in the management of dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2005; 76:1200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/91\">",
"      Mega MS, Masterman DL, Benson DF, et al. Dementia with Lewy bodies: reliability and validity of clinical and pathologic criteria. Neurology 1996; 47:1403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/92\">",
"      Galasko D, Katzman R, Salmon DP, Hansen L. Clinical and neuropathological findings in Lewy body dementias. Brain Cogn 1996; 31:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/93\">",
"      Beyer MK, Larsen JP, Aarsland D. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies. Neurology 2007; 69:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/94\">",
"      Lee JE, Park HJ, Park B, et al. A comparative analysis of cognitive profiles and white-matter alterations using voxel-based diffusion tensor imaging between patients with Parkinson's disease dementia and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2010; 81:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/95\">",
"      Seppi K, Rascol O. Dementia with Lewy bodies and Parkinson disease with dementia: can MRI make the difference? Neurology 2007; 69:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/96\">",
"      Litvan I, Campbell G, Mangone CA, et al. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study. Brain 1997; 120 ( Pt 1):65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/97\">",
"      Litvan I, Agid Y, Jankovic J, et al. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology 1996; 46:922.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/98\">",
"      Quinn N. Parkinsonism--recognition and differential diagnosis. BMJ 1995; 310:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/99\">",
"      Litvan I, Mega MS, Cummings JL, Fairbanks L. Neuropsychiatric aspects of progressive supranuclear palsy. Neurology 1996; 47:1184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/100\">",
"      Christine CW, Aminoff MJ. Clinical differentiation of parkinsonian syndromes: prognostic and therapeutic relevance. Am J Med 2004; 117:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/101\">",
"      Bak TH, Crawford LM, Hearn VC, et al. Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA). Neurocase 2005; 11:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/102\">",
"      Brown RG, Lacomblez L, Landwehrmeyer BG, et al. Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain 2010; 133:2382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/103\">",
"      Portet F, Scarmeas N, Cosentino S, et al. Extrapyramidal signs before and after diagnosis of incident Alzheimer disease in a prospective population study. Arch Neurol 2009; 66:1120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/104\">",
"      Dalrymple-Alford JC, MacAskill MR, Nakas CT, et al. The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology 2010; 75:1717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/105\">",
"      Miyasaki JM, Shannon K, Voon V, et al. Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2006; 66:996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/106\">",
"      Leentjens AF, Verhey FR, Luijckx GJ, Troost J. The validity of the Beck Depression Inventory as a screening and diagnostic instrument for depression in patients with Parkinson's disease. Mov Disord 2000; 15:1221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/107\">",
"      Leentjens AF, Verhey FR, Lousberg R, et al. The validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson's disease. Int J Geriatr Psychiatry 2000; 15:644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/108\">",
"      Naarding P, Leentjens AF, van Kooten F, Verhey FR. Disease-specific properties of the Rating Scale for Depression in patients with stroke, Alzheimer's dementia, and Parkinson's disease. J Neuropsychiatry Clin Neurosci 2002; 14:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/109\">",
"      Aarsland D, Larsen JP, Karlsen K, et al. Mental symptoms in Parkinson's disease are important contributors to caregiver distress. Int J Geriatr Psychiatry 1999; 14:866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/110\">",
"      Levy G, Tang MX, Louis ED, et al. The association of incident dementia with mortality in PD. Neurology 2002; 59:1708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/111\">",
"      Weintraub D, Moberg PJ, Duda JE, et al. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease. J Am Geriatr Soc 2004; 52:784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/112\">",
"      Aarsland D, Larsen JP, Tandberg E, Laake K. Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study. J Am Geriatr Soc 2000; 48:938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/113\">",
"      Rolinski M, Fox C, Maidment I, McShane R. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease. Cochrane Database Syst Rev 2012; 3:CD006504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/114\">",
"      Emre M, Aarsland D, Albanese A, et al. Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med 2004; 351:2509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/115\">",
"      Maidment I, Fox C, Boustani M. Cholinesterase inhibitors for Parkinson's disease dementia. Cochrane Database Syst Rev 2006; :CD004747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/116\">",
"      Ravina B, Putt M, Siderowf A, et al. Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study. J Neurol Neurosurg Psychiatry 2005; 76:934.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/117\">",
"      Aarsland D, Laake K, Larsen JP, Janvin C. Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study. J Neurol Neurosurg Psychiatry 2002; 72:708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/118\">",
"      Linazasoro G, Lasa A, Van Blercom N. Efficacy and safety of donepezil in the treatment of executive dysfunction in Parkinson disease: a pilot study. Clin Neuropharmacol 2005; 28:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/119\">",
"      Aarsland D, Hutchinson M, Larsen JP. Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia. Int J Geriatr Psychiatry 2003; 18:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/120\">",
"      Grace J, Amick MM, Friedman JH. A double-blind comparison of galantamine hydrobromide ER and placebo in Parkinson disease. J Neurol Neurosurg Psychiatry 2009; 80:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/121\">",
"      Dubois B, Tolosa E, Katzenschlager R, et al. Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study. Mov Disord 2012; 27:1230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/122\">",
"      Minett TS, Thomas A, Wilkinson LM, et al. What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia. Int J Geriatr Psychiatry 2003; 18:988.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/123\">",
"      Aarsland D, Ballard C, Walker Z, et al. Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial. Lancet Neurol 2009; 8:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/124\">",
"      Emre M, Tsolaki M, Bonuccelli U, et al. Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2010; 9:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/125\">",
"      Leroi I, Overshott R, Byrne EJ, et al. Randomized controlled trial of memantine in dementia associated with Parkinson's disease. Mov Disord 2009; 24:1217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/126\">",
"      Ridha BH, Josephs KA, Rossor MN. Delusions and hallucinations in dementia with Lewy bodies: worsening with memantine. Neurology 2005; 65:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/127\">",
"      Menendez-Gonzalez M, Calatayud MT, Blazquez-Menes B. Exacerbation of Lewy bodies dementia due to memantine. J Alzheimers Dis 2005; 8:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/128\">",
"      Monastero R, Camarda C, Pipia C, Camarda R. Visual hallucinations and agitation in Alzheimer's disease due to memantine: report of three cases. J Neurol Neurosurg Psychiatry 2007; 78:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/129\">",
"      Aarsland D, Perry R, Larsen JP, et al. Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias. J Clin Psychiatry 2005; 66:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/130\">",
"      Fernandez HH, Trieschmann ME, Burke MA, Friedman JH. Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies. J Clin Psychiatry 2002; 63:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/131\">",
"      Morgante L, Epifanio A, Spina E, et al. Quetiapine versus clozapine: a preliminary report of comparative effects on dopaminergic psychosis in patients with Parkinson's disease. Neurol Sci 2002; 23 Suppl 2:S89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/132\">",
"      Molloy SA, Rowan EN, O'Brien JT, et al. Effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2006; 77:1323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/133\">",
"      Cools R, Barker RA, Sahakian BJ, Robbins TW. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cereb Cortex 2001; 11:1136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/134\">",
"      Cools R. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease. Neurosci Biobehav Rev 2006; 30:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/135\">",
"      Mattis PJ, Tang CC, Ma Y, et al. Network correlates of the cognitive response to levodopa in Parkinson disease. Neurology 2011; 77:858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/136\">",
"      Okun MS, Tagliati M, Pourfar M, et al. Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers. Arch Neurol 2005; 62:1250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/36/15946/abstract/137\">",
"      Parsons TD, Rogers SA, Braaten AJ, et al. Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a meta-analysis. Lancet Neurol 2006; 5:578.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5089 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-200.167.4.114-2B3BC00349-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_36_15946=[""].join("\n");
var outline_f15_36_15946=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H29\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Genetic factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      NEUROPATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Neuropathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Neurotransmitter systems",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Cognitive features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Neuropsychiatric features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Cardinal motor features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Other features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Clinical course",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Dementia with Lewy bodies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Progressive supranuclear palsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Multiple systems atrophy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Corticobasal degeneration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Alzheimer disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Cerebrovascular disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Other considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Cholinesterase inhibitors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Memantine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Psychosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Motor parkinsonism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/5089\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/5089|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?21/3/21564\" title=\"table 1\">",
"      Motor features of Parkinson disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/44/3787\" title=\"table 2\">",
"      Nonmotor symptoms of Parkinson disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1913?source=related_link\">",
"      Cholinesterase inhibitors in the treatment of dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1914?source=related_link\">",
"      Clinical features and diagnosis of dementia with Lewy bodies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/33/27162?source=related_link\">",
"      Clinical manifestations and diagnosis of Alzheimer disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/13/14554?source=related_link\">",
"      Clinical manifestations of Parkinson disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/14/5354?source=related_link\">",
"      Corticobasal degeneration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/30/26089?source=related_link\">",
"      Diagnosis of Parkinson disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/41/34455?source=related_link\">",
"      Epidemiology, pathology, and pathogenesis of dementia with Lewy bodies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/57/37786?source=related_link\">",
"      Etiology, clinical manifestations, and diagnosis of vascular dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/25/28057?source=related_link\">",
"      Evaluation of cognitive impairment and dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/17/21784?source=related_link\">",
"      Management of comorbid problems associated with Parkinson disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/33/26138?source=related_link\">",
"      Mild cognitive impairment: Prognosis and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?14/37/14934?source=related_link\">",
"      Patient information: Dementia (including Alzheimer disease) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?13/40/13954?source=related_link\">",
"      Patient information: Parkinson disease (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?5/4/5188?source=related_link\">",
"      Patient information: Parkinson disease symptoms and diagnosis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/63/32762?source=related_link\">",
"      Pharmacologic treatment of Parkinson disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/61/43994?source=related_link\">",
"      Pharmacology of antiepileptic drugs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/34/21031?source=related_link\">",
"      Prognosis and treatment of dementia with Lewy bodies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27402?source=related_link\">",
"      Treatment of behavioral symptoms related to dementia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f15_36_15947="Stool electrolytes";
var content_f15_36_15947=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F51596&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F51596&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Interpretation of stool electrolytes",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"3\">",
"       Calculation of the osmotic gap",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"3\">",
"       Stool osmotic gap = 290 - estimated stool osmolality",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"3\">",
"       Estimated stool osmolality = 2 x ([Na",
"       <sub>",
"        stool",
"       </sub>",
"       + K",
"       <sub>",
"        stool",
"       </sub>",
"       ])",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"3\">",
"       Laboratory tests aiding the differentiation between secretory and osmotic diarrhea",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Laboratory tests",
"      </td>",
"      <td class=\"subtitle2_single\">",
"       Secretory",
"      </td>",
"      <td class=\"subtitle2_single\">",
"       Osmotic",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Osmotic gap",
"      </td>",
"      <td class=\"indent1\">",
"       &lt;50 mOsm/kg",
"      </td>",
"      <td class=\"indent1\">",
"       &gt;125 mOsm/kg",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       pH",
"      </td>",
"      <td class=\"indent1\">",
"       &gt;6.0",
"      </td>",
"      <td class=\"indent1\">",
"       &lt;5.5",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Richard Kellermayer, MD, PhD and Robert J Shulman, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_36_15947=[""].join("\n");
var outline_f15_36_15947=null;
var title_f15_36_15948="Causes malnutrition elders";
var content_f15_36_15948=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F54156&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F54156&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Mnemonic for common causes of malnutrition in elders",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        MEALS ON WHEELS",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         M",
"        </strong>",
"       </td>",
"       <td>",
"        Medications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         E",
"        </strong>",
"       </td>",
"       <td>",
"        Emotional problems (depression)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         A",
"        </strong>",
"       </td>",
"       <td>",
"        Anorexia (nervosa or tardive)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         L",
"        </strong>",
"       </td>",
"       <td>",
"        Late-life paranoia or alcoholism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         S",
"        </strong>",
"       </td>",
"       <td>",
"        Swallowing disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist_other\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         O",
"        </strong>",
"       </td>",
"       <td>",
"        Oral factors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         N",
"        </strong>",
"       </td>",
"       <td>",
"        No money",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist_other\" colspan=\"2\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         W",
"        </strong>",
"       </td>",
"       <td>",
"        Wandering (in patients with dementia)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         H",
"        </strong>",
"       </td>",
"       <td>",
"        Hyperthyroidism, hyperparathyroidism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         E",
"        </strong>",
"       </td>",
"       <td>",
"        Entry problems/malabsorption",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         E",
"        </strong>",
"       </td>",
"       <td>",
"        Eating problems (severe tremor, stroke, weakness)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         L",
"        </strong>",
"       </td>",
"       <td>",
"        Low-salt or low-cholesterol diets",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         S",
"        </strong>",
"       </td>",
"       <td>",
"        Shopping and food preparation problems",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Saint Louis University Geriatric Evaluation Mnemonics Screening Tools. Compiled by faculty from Saint Louis University Geriatrics Division. Copyright &copy;2002 Saint Louis University.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_36_15948=[""].join("\n");
var outline_f15_36_15948=null;
var title_f15_36_15949="Plat combinations NSCLC";
var content_f15_36_15949=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F62287&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F62287&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Platinum-based combination regimens for advanced NSCLC",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Regimen",
"      </td>",
"      <td class=\"subtitle1\">",
"       Dose and schedule",
"      </td>",
"      <td class=\"subtitle1\">",
"       Frequency",
"      </td>",
"      <td class=\"subtitle1\">",
"       Reference",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       Carboplatin/Paclitaxel",
"      </td>",
"      <td>",
"       <p>",
"        Paclitaxel 225 mg/m2 over 3 hours",
"       </p>",
"       <p>",
"        Carboplatin AUC 6 mg/mL/min",
"       </p>",
"      </td>",
"      <td>",
"       Every 3 weeks",
"      </td>",
"      <td>",
"       J Clin Oncol 2005; 23:190",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <p>",
"        Paclitaxel 100 mg/m2",
"       </p>",
"       <p>",
"        Carboplatin AUC 2 mg/mL/min",
"       </p>",
"      </td>",
"      <td>",
"       Weekly",
"      </td>",
"      <td>",
"       Clin Lung Cancer 2006; 7:338",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Cisplatin/Etoposide",
"      </td>",
"      <td>",
"       <p>",
"        Cisplatin 100 mg/m2",
"       </p>",
"       <p>",
"        Etoposide 100 mg/m2 days 1, 2, 3",
"       </p>",
"      </td>",
"      <td>",
"       Every 3 weeks",
"      </td>",
"      <td>",
"       Ann Oncol 1997; 8:525",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Cisplatin/Vinorelbine",
"      </td>",
"      <td>",
"       <p>",
"        Cisplatin 100 mg/m2 day 1",
"       </p>",
"       <p>",
"        Vinorelbine 25 mg/m2 days 1, 8, 15, 22",
"       </p>",
"      </td>",
"      <td>",
"       Every 4 weeks",
"      </td>",
"      <td>",
"       J Clin Oncol 1998; 16:2459",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Cisplatin/Paclitaxel",
"      </td>",
"      <td>",
"       <p>",
"        Cisplatin 75 mg/m2",
"       </p>",
"       <p>",
"        Paclitaxel 135 mg/m2",
"       </p>",
"      </td>",
"      <td>",
"       Every 3 weeks",
"      </td>",
"      <td>",
"       J Clin Oncol 2000; 18:623",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Cisplatin/Docetaxel",
"      </td>",
"      <td>",
"       <p>",
"        Cisplatin 75 mg/m2",
"       </p>",
"       <p>",
"        Docetaxel 75 mg/m2",
"       </p>",
"      </td>",
"      <td>",
"       Every 3 weeks",
"      </td>",
"      <td>",
"       J Clin Oncol 2003; 21:3016",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Carboplatin/Docetaxel",
"      </td>",
"      <td>",
"       <p>",
"        Carboplatin AUC 6 mg/mL/min",
"       </p>",
"       <p>",
"        Docetaxel 75 mg/m2",
"       </p>",
"      </td>",
"      <td>",
"       Every 3 weeks",
"      </td>",
"      <td>",
"       J Clin Oncol 2003; 21:3016",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Cisplatin/Gemcitabine",
"      </td>",
"      <td>",
"       <p>",
"        Cisplatin 100 mg/m2 day 1",
"       </p>",
"       <p>",
"        Gemcitabine 1000 mg/m2 days 1, 8, 15",
"       </p>",
"      </td>",
"      <td>",
"       Every 4 weeks",
"      </td>",
"      <td>",
"       J Clin Oncol 2000; 18:122",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Cisplatin/Pemetrexed",
"      </td>",
"      <td>",
"       <p>",
"        Cisplatin 75 mg/m2 day 1",
"       </p>",
"       <p>",
"        Pemetrexed 500 mg/m2 day 1",
"       </p>",
"      </td>",
"      <td>",
"       Every 3 weeks",
"      </td>",
"      <td>",
"       Scagliotti, G. J Clin Oncol 2008",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Carboplatin/Gemcitabine",
"      </td>",
"      <td>",
"       <p>",
"        Carboplatin AUC 5 mg/mL/min",
"       </p>",
"       <p>",
"        Gemcitabine 1200 mg/m2 days 1, 8",
"       </p>",
"      </td>",
"      <td>",
"       Every 3 weeks",
"      </td>",
"      <td>",
"       Lung Cancer 2003; 41:321",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Cisplatin/Irinotecan",
"      </td>",
"      <td>",
"       <p>",
"        Cisplatin 80 mg/m2 day 1",
"       </p>",
"       <p>",
"        Irinotecan 60 mg/m2 days 1, 8, 15",
"       </p>",
"      </td>",
"      <td>",
"       Every 4 weeks",
"      </td>",
"      <td>",
"       Proc Am Soc Clin Oncol 2004; 22:618s",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Carboplatin/Paclitaxel/Bevacizumab",
"      </td>",
"      <td>",
"       <p>",
"        Carboplatin AUC 6 mg/mL/min day 1",
"       </p>",
"       <p>",
"        Paclitaxel 200 mg/m2 day 1",
"       </p>",
"       <p>",
"        Bevacizumab 15 mg/kg day 1",
"       </p>",
"      </td>",
"      <td>",
"       Every 3 weeks*",
"      </td>",
"      <td>",
"       N Engl J Med 2006; 355:2542",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Carboplatin/Pemetrexed",
"      </td>",
"      <td>",
"       <p>",
"        Carboplatin AUC 5 mg/mL/min day 1",
"       </p>",
"       <p>",
"        Pemetrexed 500 mg/m2 day 1",
"       </p>",
"      </td>",
"      <td>",
"       Every 3 weeks",
"      </td>",
"      <td>",
"       J Clin Oncol 2007; 25:388s",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Carboplatin/Vinorelbine",
"      </td>",
"      <td>",
"       <p>",
"        Carboplatin AUC 4 day 1",
"       </p>",
"       <p>",
"        Vinorelbine 25 mg/m2 day 1",
"       </p>",
"      </td>",
"      <td>",
"       Every 3 weeks",
"      </td>",
"      <td>",
"       Br J Cancer 2007; 97:283",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    These are representative doses and schedules, which have varied in different trials.",
"    <div class=\"footnotes\">",
"     AUC: Area under the concentration x time curve; NSCLC: Non-small cell lung cancer.",
"     <br>",
"      * Bevacizumab continued every 3 weeks after completion of six cycles.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_36_15949=[""].join("\n");
var outline_f15_36_15949=null;
var title_f15_36_15950="TfR ferritin index";
var content_f15_36_15950=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F79053&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F79053&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Transferrin receptor-ferritin index in anemic patients",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 427px; height: 497px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This figure shows the transferrin receptor-ferritin index (TfR-F index), the ratio of the serum TfR to the logarithm (base 10) of the serum ferritin in iron deficiency anemia (IDA, red circles), anemia of chronic disease (ACD, green squares) and those with both conditions (IDA/ACD, blue triangles). Median values are indicated by the horizontal bars. A value of &le;1.0 suggests ACD, while values &ge;2 suggest IDA or IDA/ACD.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Punnonen, K, Irjala, K, Rajamaki, A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997; 89:1052. Copyright &copy; 1997 American Society of Hematology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_36_15950=[""].join("\n");
var outline_f15_36_15950=null;
var title_f15_36_15951="Hypoplasia lymphoid tissue";
var content_f15_36_15951=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F62709&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F62709&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 494px\">",
"   <div class=\"ttl\">",
"    Normal adenoid (left); absent adenoid in agammaglobulinemia (right)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 474px; height: 216px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Douglas J Barrett, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_36_15951=[""].join("\n");
var outline_f15_36_15951=null;
